Search
Boards Fodder: Procedural dermatology
Select a title below to access the Boards Fodder PDF. ... NEW! Flap update 2025: Part 2 sliding flaps ... Access the PDF Alopecia areata treatment Antiseptics and sterilization methods Approach to longitudinal melanonychia Atopic dermatitis treatment Biopsy techniques Chemical peels Cosmeceuticals CPT billing codes of common procedures Cryosurgery Derm
Session handouts and meetings archive
Handouts ... 2025 Innovation Academy, Chicago, IL, July 10-13 2025 Annual Meeting, Orlando, FL, March 7-11 2024 Innovation Academy, Seattle, WA, August 1-4 2024 Annual Meeting, San Diego, CA, March 8-12 2023 Innovation Academy, Tampa, FL, August 10-13 2023 Annual Meeting, New Orleans, LA, March 17-21 Sessions ... 2025 Innovation
Step 3: Small and large practice reporting options
Access the PDF ... See a PDF version of the Academy ... ’ s ... practice reporting options . ... Review these reporting options for small practices (15 providers or fewer) and large practices (16 providers or more) to help achieve the minimum and maximum points needed to either avoid
CME & session evaluation archive
Claim CME & submit session evaluations ... Claim CME credit and submit session evaluations for attending previous Academy meetings: ... 2025 Innovation Academy, Chicago, IL, July 10-13 2025 Annual Meeting, Orlando, FL, March 7-11 2024 Innovation Academy, Seattle, WA, August 1-4 2024 Annual Meeting, San Diego, CA, March 8-12 2023
Find drug prices in your area
The cost of medications is a barrier for many patients, particularly those without insurance or those whose prescription is not covered by insurance. You can search for drug prices in your area by visiting ... GoodRx . ... Additional assistance ... There are also several programs available for patients to
AADA hosts largest Capitol Hill skin cancer check in a decade
On May 15, the AADA hosted its 10th annual Capitol Hill Skin Cancer Check and Health Fair with the Congressional Skin Cancer Caucus. This event was our largest to date, hosting 198 Hill staffers and 11 members of Congress, performing 127 skin checks, and providing 75 Reveal camera image results.
May 2
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / MAY 2, 2018 ... The clock is ticking: Only a few days left to review your Sunshine Act info PBMs cutting copay coupons from patient deductibles — which could mean soaring
October 2, 2019
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / October 2, 2019 ... Does gluten increase risk for psoriasis and AD in women? DW Insights and Inquiries : Cutting giant congenital nevi down to size molecularly Upcoming coding changes: Differentiating
Dermatopathology’s taste of honey
By Warren R. Heymann, MD September 2, 2020 Vol. 2, No. 35 Recently, on our consult service, my resident and I were assessing a patient with a potential autoimmune bullous disease; we concurred that a skin biopsy for routine microscopy and direct immunofluorescence (DIF) was warranted. "I’ll have to come
Pigmented onychomatricoma: Avoid getting nailed by misdiagnosis
By Warren R. Heymann, MD Dec. 2, 2020 Vol. 2, No. 47 Rightfully, monodactylous linear melanonychia should make any dermatologist nervous, with or without a Hutchinson sign. No nail unit melanoma should be left behind. ... Longitudinal melanonychia (LM) is defined as a longitudinally oriented band of brown-black pigment in
An old dog with a new trick: High dose intralesional steroids in hidradenitis suppurativa
By Warren R. Heymann, MD, FAAD February 2, 2022 Vol. 4, No. 5 Hidradenitis suppurativa (HS) is hitting its stride academically — deservedly so. In 2000 there were 2 publications about HS in the ... Journal of the American Academy of Dermatology ; in 2010, 9 manuscripts; and, in 2020,
Tofacitinib for dermatomyositis: A potential belle of the ball?
By Warren R. Heymann, MD Aug. 23, 2016 JAK1/3 signaling participates in the pathogenesis of inflammatory disorders while JAK1/2 signaling plays a role in the development of several malignancies including leukemias, lymphomas, and myeloproliferative neoplasms. Tofacitinib (Xeljans) is a pan-JAK inhibitor that is approved by the FDA for the treatment
Touching on contact pemphigus and pemphigus-like eruptions due to imiquimod
By Warren Heymann, MD June 2, 2021 Vol. 3, No. 22 Most astute medical dermatologists are aware of drug-induced pemphigus, but many (including myself) may not be as familiar with topical medications being the responsible culprits. This commentary will focus on imiquimod-induced pemphigus and pemphigus-like eruptions (PLE). ... My curiosity
Excludes notes
ICD-10 Excludes notes: In a nutshell ... ICD-10-CM codes include two sets of exclusions. ... Excludes 1 exclusions indicate when two codes cannot be billed at the same time. ... Excludes 2 exclusions indicate that the codes are separately billable. ... Excludes 1 Note ... Within the ICD-10-CM manual, you
The rhythm of RIME
By Warren R. Heymann, MD, FAAD March 2, 2022 Vol. 4, No. 9 Mucosal ulceration urgently gets everyone’s attention. How many times have you been asked to evaluate a patient for suspected Stevens-Johnson syndrome (SJS)? It is not always an easy task to differentiate erythema multiforme (EM) from pemphigus vulgaris,
Incretin-based therapy for diabetes and dermatology: Promise and peril
By Warren R. Heymann, MD Oct. 23, 2017 In a given day, how many of your patients are diabetic? According to the American Diabetes Association, in 2015, 9.4% of the US population (30.3 million) were diabetic; 29 million of this group had type 2 diabetes. ... Incretin hormones refer to
Lipodystrophia semicircularis: A lipoatrophy not to get depressed about
By Warren R. Heymann, MD, FAAD Nov. 2, 2022 Vol. 4, No. 44 A colleague asked me if I could evaluate his 26-year-old daughter while she was briefly on break from her graduate studies in Barcelona. He was concerned that she had developed lipodystrophy. Of course, I agreed, without his
April 2, 2025
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / April 2, 2025 ... Oral vs. topical minoxidil in patients with androgenetic alopecia DermWorld Insights and Inquiries : Becoming ‘sensitized’ to the clinical utility of the term "urticarial dermatitis" (a subtype
September 2, 2020
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / September 2, 2020 ... What role can dermatologists play in developing a COVID-19 vaccine? DW Insights and Inquiries : Dermatopathology’s taste of honey Non-discrimination protections change under ACA Skin of color
August 2, 2023
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / August 2, 2023 ... Isotretinoin for seborrheic dermatitis: A review DermWorld Insights and Inquiries : Cellular neurothekeoma: A tribute to Barnhill and Mihm and a remembrance of Martin C. Mihm Jr.,
July 2, 2025
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / July 2, 2025 ... Isotretinoin for seborrheic dermatitis DermWorld Insights and Inquiries : Turning our attention to melanoma risk in Turner syndrome CMS updates MUE limit for Ameluz — Effective July
February 2, 2022
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Feb. 2, 2022 ... A high-fiber diet may affect immunotherapy response for melanoma patients DermWorld Insights and Inquiries : An old dog with a new trick — High dose intralesional steroids
November 2, 2022
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Nov. 2, 2022 ... Factors that influence platelet rich plasma efficacy in androgenetic alopecia DermWorld Insights and Inquiries : Lipodystrophia semicircularis — A lipoatrophy not to get depressed about Underlying conditions
October 2, 2024
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / October 2, 2024 ... Risk of IBD in patients receiving isotretinoin DermWorld Insights and Inquiries : The pregnant pause in cutaneous lymphoma Hydroxychloroquine in patients with lichen sclerosus Abrocitinib vs. dupilumab
December 2, 2020
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Dec. 2, 2020 ... Surgical vs non-surgical interventions for basal cell carcinoma DermWorld Insights and Inquiries : Pigmented onychomatricoma — Avoid getting nailed by misdiagnosis Derm Coding Consult : Coding for
June 2, 2021
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / June 2, 2021 ... Acne and enthesitis: Is there an association? DermWorld Insights and Inquiries : Touching on contact pemphigus and pemphigus-like eruptions due to imiquimod Derm Coding Consult : Applying
March 2, 2022
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / March 2, 2022 ... Biotin beware: Physician, patient knowledge about lab interference DermWorld Insights and Inquiries : The rhythm of RIME Infections in children treated with dupilumab Cutaneous adverse events are
We’ve gotta recognize GATA2 deficiency
Cutaneous findings in GATA2 deficiency. (A) Extensive human papillomavirus infection with vulvar and anal intraepithelial neoplasia, (B) cutaneous mycobacterial infection, and (C) erythema nodosum–like panniculitis in a 40-year-old woman with GATA2 deficiency. ... Credit: ... JAAD By Warren R. Heymann, MD Dec. 26, 2018 I’ll begin with my conclusion —
Components of evaluation and management 2
Cracking the Code ... Dr. Miller, who is in private practice in Yorba Linda, California, represents the American Academy of Dermatology on the AMA-CPT Advisory Committee. ... By Alexander Miller, MD, June 1, 2018 Test your knowledge: Components of evaluation and management 2 ... Take the quiz to see if
The profound dermatological manifestations of COVID-19: Part II
By Warren R. Heymann, MD March 25, 2020 Vol. 2, No. 12 Disclaimers: This commentary was written on March 17, 2020 for a publication date of March 25, 2020. The issues related to the COVID-19 pandemic are changing like lightning. The content included in this commentary may no longer be
Biopsy coding in 2019: Part 2
Cracking the Code ... Dr. Miller, who is in private practice in Yorba Linda, California, represents the American Academy of Dermatology on the AMA-CPT Advisory Committee. ... By Alexander Miller, MD, December 3, 2018 Test your knowledge: Biopsy coding in 2019 — Part 2 ... Take the quiz to see
Researching therapeutic reformation of the capillary malformation: Arteriovenous Malformation Syndrome
By Warren R. Heymann, MD June 17, 2020 Vol. 2, No. 24 Small cutaneous lesions may have profound systemic implications. Astute dermatologists will recognize these lesions and assess patients accordingly, often to the surprise of referring physicians and patients alike. ... The Capillary Malformation – Arteriovenous Malformation (CM-AVM) syndrome was
Evaluation and management in 2021: Part 2
Cracking the code ... Dr. Miller, who is in private practice in Yorba Linda, California, represents the American Academy of Dermatology on the AMA-CPT Advisory Committee. ... By Alexander Miller, MD, October 1, 2020 Test your knowledge: Evaluation and management in 2021: Part 2 ... Take the quiz to see
Being there
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... DW Weekly talked to Diana Bartenstein, MD, a PGY-2 dermatology resident at Massachusetts General Hospital, about her work as a responding clinician on an inpatient COVID-19 ward. For too many COVID-19 patients, the end has
CPT 2018: What's new, part 2
Cracking the Code ... Dr. Miller, who is in private practice in Yorba Linda, California, represents the American Academy of Dermatology on the AMA-CPT Advisory Committee. ... By Alexander Miller, MD, January 1, 2018 Test your knowledge – CPT 2018: What's new, part 2 ... Take the quiz to see
I don’t know JAK — but I will! Ruxolitinib improving chilblain lupus erythematosus
By Warren R. Heymann, MD May 31, 2016 The JAK inhibitors are among the current darlings of treating autoimmune diseases. Recent articles about tofacitinib for vitiligo (1) and alopecia areata (2) have been reported in the lay press with considerable fanfare. ... Ruxolitinib (Jakafi) is indicated for treating intermediate to
Intermediate and complex repairs 2020: Part 2
Cracking the Code ... Dr. Miller, who is in private practice in Yorba Linda, California, represents the American Academy of Dermatology on the AMA-CPT Advisory Committee. ... By Alexander Miller, MD, November 1, 2019 Intermediate and complex repairs 2020: Part 2 ... Take the quiz to see if you're up
Topical crisaborole ointment for atopic dermatitis: Hoping for a painless introduction
By Warren R. Heymann, MD Aug. 13, 2016 Any dermatologist who treats atopic dermatitis (AD) must be eagerly awaiting the introduction of 2% Crisaborole ointment. This is equally true for patients (and their parents!) who are steroid-phobic and uncomfortable with the black box warning for calcineurin inhibitors (despite our reassurances).
Small group practice (6-15 practitioners)
Best for: Dermatologists seeking clinical autonomy, peer collaboration, and work-life balance without solo ownership responsibilities. ... Quick summary: Join a privately owned dermatology group with a small number of physician partners. It offers more control than you’ll find in large settings, but also more help than a solo practice. A
Ustekinumab: A topic for atopics?
By Warren R. Heymann, MD Jan. 9, 2017 Atopic dermatitis patient shows drastic improvement at week 19 of ustekinumab treatment. ... Credit: ... JAAD If you’re like me, you have a cadre of patients with severe atopic dermatitis (AD) patients who are counting the minutes for the release of
The concept of atrophoderma of pasini and pierini as morphea may be falling off a cliff
By Warren R. Heymann, MD Nov. 6, 2017 ... Clinical photos of idiopathic atrophoderma of Pierini and Pasini. ... Credit: ... JAAD Diagnosing Atrophoderma of Pasini and Pierini (APP) is reasonably straightforward — it usually presents in adolescents and young adults, more often in females, with sharply defined, single or
Advocating for you — Preventing Medicare cuts
Persistence keeps Medicare cuts at bay ... Medicare is front and center again as we build on last year’s win, successfully fending off physician payment cuts due to the Medicare sequester during the COVID-19 public health emergency. After the moratorium on the regular 2% Medicare payment cuts was extended through
Digital media kit: DermWorld editorial calendar
Download a PDF of the 2026 DermWorld editorial calendar . ... JANUARY ... FEBRUARY ... MARCH ... Preparing derms to use ... GLP-1 RA Coding: Soft tissue excision ... Managing declining morale in health care ... Close: 11/25/25 ... Materials due: 12/3/25 ... Mail date: 1/2/26 ... Update on ...
A Trumpian analysis of infliximab-induced follicular mucinosis: Something’s going on here
By Warren R. Heymann, MD July 10, 2016 Williams et al presented two cases of biopsy-proven facial follicular mucinosis (FM), apparently induced by infliximab, with a normal tissue CD4/CD8 ratio of 2/1 and the presence of CD7, thereby ruling out CTCL. The first case was a 23 year-old man with
June 5
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / June 5, 2019 ... Self-injection of black market dermal fillers poses health concern DW Insights and Inquiries : Stress 2 ... + Hormones 2 ... = Acne 2 ... CMS/NCCI announce
Tofacitinib for adolescent alopecia areata: Balancing the risk-benefit ratio
By Warren R. Heymann, MD Jan. 17, 2017 Alopecia areata with patient 4 after 2 months of treatment with 2% tofacitinib in VersaBase cream (A) and after 6 months of treatment with 2% tofacitinib in liposomal base (B). ... Credit: ... JAAD There has been acute interest in utilizing Janus
Will PD-1 inhibitors be msed for Mastocytosis?
By Warren R. Heymann, MD May 8, 2016 Kuklinski L, Kim J. Expression of PD-L1 in mastocytosis. J Am Acad Dermatol 2016; 74: 1010-2. ... The authors evaluated 16 specimens from 12 patients with mastocytosis, using immunohistochemical stains for PD-L1, CD-117, and mast cell tryptase on all specimens. Of the12
November 18, 2020
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / November 18, 2020 ... Hydrogen peroxide and the common wart: Phase 2 results are in DermWorld Insights and Inquiries : Granulomatous slack skin — More than one type of mimicry FDA
Exchanging plasma exchange for a novel approach: The potential of FcRn antagonists in dermatologic autoimmune disease
By Warren R. Heymann, MD, FAAD Nov. 1, 2023 Vol. 5, No. 44 Pemphigus vulgaris (PV) and pemphigus foliaceus (PF) are potentially life-threatening disorders demanding aggressive therapy with all the finesse and skill that dermatologists can muster. PV is characterized by IgG autoantibodies targeting desmoglein (Dsg)‐3, which is associated with
Stress^2 + Hormones^2 = Acne^2
By Warren R. Heymann, MD June 5, 2019 Vol. 1, Issue 13 I would wager that every human being has experienced at least one pimple attributed to stress. I recall a devastatingly embarrassing moment during 10th grade world history class at Martin Van Buren High School (Queens, New York), when
Sézary syndrome and Shakespeare: What’s in a name?
By Warren R. Heymann, MD ... March 24, 2017 ... Initial clinical presentations of Sézary syndrome without erythroderma. Normal-appearing skin with moderate pigmentation on back of patient 2 (A), several seborrheic keratoses and a hematoma secondary to skin biopsy for patient 3 (B), no apparent lesion on back of
Neurofibromatosis type 1, juvenile xanthogranuloma, and leukemia: Wasting a good worry?
By Warren R. Heymann, MD May 22, 2017 A clinically pigmented neurofibroma associated with underlying café au lait macule. ... Credit: ... JAAD Worry comes with the territory of Neurofibromatosis Type I (NF-1). It often starts with the anxiety of determining if a child has enough criteria to confirm the
What is the status of MAC implementation of the NCCI new procedure to procedure edits for the new biopsy codes?
Asked and Answered ... August 1, 2019 As of July 1, 2019, service modifiers 59 and XE, XS, XP, and XU may be appended to either Column 1 or Column 2 codes in the National Correct Coding Initiative (NCCI) Procedure-to-Procedure (PTP) edits table, when appropriate. On March 29, the Centers
October 12, 2022
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Oct. 12, 2022 ... Type 2 diabetes and CCCA severity DermWorld Insights and Inquiries : Fixing the concept of the neutrophilic fixed drug eruption What’s the risk of IBD in patients
What MIPS deadlines are coming up and when do I have to submit?
Asked and Answered ... September 2, 2019 Mark your calendars with the following MIPS reporting deadlines: Oct. 2, 2019: ... Last day to begin an improvement activity (IA) or participate in promoting interoperability (PI) measures as these require 90 consecutive days of engagement ... Dec. 1, 2019 ... (for EHR
Working up pernio: How far should you dip your toe in the water?
By David A. Wetter, MD May 6, 2020 Vol. 2, No. 18 Dermatologists are rapidly becoming reacquainted with pernio (chilblains), given the increasing reports of pernio-like acral eruptions (and other dermatologic manifestations) occurring in association with COVID-19. (1, 2) This raises an important clinical question: under normal (non-COVID-19) circumstances, what
Raising a toast to advances in treating alcohol-induced flushing
By Warren R. Heymann, MD November 11, 2020 Vol. 2, No. 45 Whether with pride or embarrassment, we have all blushed. Also known as flushing, the process is defined as a visible reddening of the skin accompanied by a sensation of warmth, characteristically affecting the face, ears, neck, and upper
Here comes the sun: The role of polypodium leucotomos extract
By Warren R. Heymann, MD Aug. 9, 2017 Ultraviolet (UV)B response. Changes in biomarkers of UV radiation exposure before and after Polypodium leucotomos extract (PLE). A, Stained nuclei for cyclobutane pyrimidine dimers (CPD), Ki67, proliferating cell nuclear antigen (PCNA), and cyclin D1. B, Sunburn cells and cytoplasmic staining for cyclooxygenase-2
Cannabinoids may elevate therapy for connective tissue diseases to a higher level
By Warren R. Heymann, MD Nov. 2, 2017 Medical "reefer madness" is taking hold in the United States with approximately 10% of cannabis users utilizing it for diverse medical conditions, including dermatologic disorders such as pruritus and atopic dermatitis. To date, at least 28 states allow for the use of
Getting within a hair’s breadth of understanding prurigo pigmentosa
By Warren R. Heymann, MD March 2, 2017 Prurigo pigmentosa is an uncommon, acquired inflammatory disorder with a predilection for young adults of Asian descent. A 30-year-old Chinese man presented with reticulated erythematous and hyperpigmented papules on his back and shoulders (A and B). The eruption was present for 2
Psoriasiform eruptions during Kawasaki disease (KD): A prognosis that lets the good times roll
By Warren R. Heymann, MD June 27, 2016 Psoriasiform skin changes have been rarely described in the literature in both acute (1-4 weeks) and convalescent phases (4-12 weeks) of KD (1). ... Haddock et al, in their review of 870 cases of KD, identified 11 patients with a psoriasiform eruption
Eye-opening news about oxymetazoline
By Warren R. Heymann, MD, FAAD April 27, 2022 Vol. 4, No. 17 Certain articles have a "wow" factor that immediately impacts practice. In 2007, I recall being impressed by the 2 cases of erythematotelangiectatic rosacea reported by Shanler and Ondo that dramatically improved with the application of oxymetazoline hydrochloride
Applying the 2021 E/M coding concepts in everyday practice – Part 3
Part three of the AADA’s clinical vignettes focuses on the application of the more challenging concepts related to the review and analysis of data in the AMA Medical Decision-Making table. Understanding the application of these concepts will assist you in determining when data may impact the level of service provided.
Moving the needle: Medicare physician payment
Advocacy News Roundup ... By Victoria Houghton, managing editor, July 1, 2021 DermWorld ... breaks down the latest highlights of AADA advocacy activities at the federal and state legislative and regulatory level. For several years, physicians have endured a 2% Medicare payment reduction as part of sequestration — a component
Paraneoplastic syndromes (PNS) associated with merkel cell carcinoma are analogous to small cell cung Cancer: A comparison to other lung cancers
By Warren R. Heymann, MD Sept. 2, 2016 Merkel cell carcinomas (MCC) are neuroendocrine tumors associated with the Merkel cell carcinoma polyomavirus in >80% of tumors (1). Small cell lung cancer, another neuroendocrine tumor, is associated with paraneoplastic syndromes (PNS) in up to 20% of cases, notably the syndrome of
Boards Fodder: Drugs and drug reactions
Select a title below to access the Boards Fodder PDF. ... NEW! UV radiation and sunscreen ... Access the PDF Advanced and immuno-therapies Adverse events from immune checkpoint inhibitors Biologics update 2019 Chemotherapy-specific cutaneous reactions Clinically relevant drug interactions in dermatology Drug interactions in dermatology, part 2 Disorders of hyperpigmentation
Fighting detrimental Medicare payment cuts
As our top federal legislative priority, your Academy fought all year against Medicare payment cuts of 8.5% or more that were scheduled to begin on Jan. 1, 2023. ... As a result, in late December, President Biden signed into law an omnibus spending package that included partial relief from the
Not aging like fine wine: The myths and mysteries of acquired port wine stains
By Warren R. Heymann, MD January 13, 2021 Vol. 3, No. 2 Port wine stains (PWS, aka nevus flammeus, nevus simplex, salmon patch) are cutaneous capillary malformations that are characteristically congenital (CPWS) but may be acquired (APWS). APWS was first described in a German publication by Fegeler in 1949, hence
Clear cell papulosis: Clearly distinctive, clearly underrecognized
By Warren R. Heymann, MD June 3, 2020 Vol. 2, No. 22 One of my greatest joys in dermatology is diagnosing a disease that I have only read about, but then encounter in life. That "aha moment" is exhilarating! When attending patient presentations at dermatology conferences, I encourage my residents
Hidradenitis suppurativa and socioeconomic status: Food for thought (and benefit)
By Warren R. Heymann, MD ... Oct. 2, 2016 ... We see many patients with hidradenitis suppurativa (HS), especially in our Camden practice. I am certainly not surprised by the well-documented comorbidities of obesity and smoking (1), which may play a role in the pathogenesis of the disease. While
Skin conditions by the numbers
Acne ... Acne is the most common skin condition in the United States, affecting up to 50 million Americans annually. (1) ... There are different types of acne (blackheads, whiteheads, pimples, acne cysts or nodules), so a one-size-fits-all approach is not the best way to achieve clearer skin. (2) A
AADA advocacy win: CMS suspends CLIA lab director enforcement policy
As a direct result of advocacy by the AADA, CMS will not enforce provisions of its revised CLIA laboratory director policy that had excluded board-certified dermatologists from directing moderate- and high-complexity laboratories. ... Specifically, CMS will: ... Allow for individuals qualified as technical supervisors to qualify as high-complexity laboratory directors
Thoughts on hyaluronidase and The House of God
By Warren R. Heymann, MD January 15, 2020 Vol. 2, No. 2 I was reminiscing about my internship at Bellevue-NYU forty years ago after reading Stephen Bergman’s (pseudonym Samuel Shem) reflections on the fortieth anniversary of his irreverent, but hilariously accurate, ... The House of God — a portrayal of
Support the AAD Teledermatology Program
Throughout the U.S., there are many underserved areas where primary care physicians do not have easy access to dermatologists. Through the ... AAD Teledermatology Program , these physicians can easily consult with volunteer dermatologists and better serve patients in need. As more clinics sign up and physicians become trained to
Monitoring infantile hemangiomas: What’s the score?
By Howard B. Pride, MD, FAAD Geisinger Medical Center, Department of Dermatology Aug. 11, 2021 Vol. 3, No. 32 Infantile hemangiomas (IH) are common vascular tumors that generally run a self-limited course of rapid growth in the first 2-3 months of life, slow growth for another 4-6 months, and then
April 7, 2021
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / April 7, 2021 ... Applying 2021 E/M coding concepts in everyday practice – Part 2 DermWorld Insights and Inquiries : Keeping an eye on melanoma AAD collaborates with OM1 to enhance
Dermatologists will increasingly meet mammalian meat allergy
By Warren R. Heymann, MD March 20, 2019 Vol 1, No. 2 It has been a decade since Van Nunen et al detailed 25 patients living in a tick-endemic region of Sydney, Australia, who developed a red meat allergy following large, local reactions to tick bites. (1) Tick-induced mammalian meat
PDF of MIPS reporting options
based on a sliding added) making each of them 50%.
PDF of Nominating Committee Member Rep. Regional Map
the PE WEST REGION OF THE UNITED STATES QC ON AND CANADIAN PROVINCES ONLY NS (Shown in Pink) ND WA
MIPS 2025 FAQs
MIPS & MACRA glossary ... APM = (Advanced) Alternative Payment Model. A payment approach that gives additional incentive payments to professionals under ACO models, or those that bear more than the nominal amount of financial risk. Most dermatologists will not be eligible for this track. There are two types of
Psoriatic disease and thyroid conditions
Research indicates that people with psoriasis and psoriatic arthritis have an increased risk of developing thyroid disease. ... Psoriatic disease and thyroid conditions ... Click to view and download the infographic. ... Download Source: ... www.jaad.org/article/S0190-9622(18)32985-2/pdf More information: ... Psoriasis Resource Center Help and Chat
PDF of Board of Directors Regional Map
NL 9 BC 40 NL AB SK MB 9 47 4 12 PE QC 1 ON 64 NS 140 20 WA ND MT NB 333 46 22
Academy physician leaders meet with federal legislators
On June 4, AADA physician leaders met with legislators in Washington, D.C., as part of the House Call on the Mall fundraiser hosted by the National Republican Congressional Committee and Rep. John Joyce, MD, FAAD (R-PA). During the event, AADA leaders reiterated the importance of Medicare physician payment reform. ...
2025 AAD Innovation Academy Attendee Statistics
Innovation Academy Attendance over the years: 2024 – Seattle, WA ..................................
Shingles and heart health
Adults who have had shingles may be at a higher risk for heart problems. ... Shingles and heart health ... Click to view and download the infographic. ... Download Sources www.reuters.com/article/us-health-shingles-heart-stroke-idUSKBN19O27U www.onlinejacc.org/content/70/2/295?download=true More information Shingles: Overview, symptoms, causes, and treatment Help and Chat
Digital media kit: DermWorld rate card
DermWorld print rates ... Download a PDF of the 2026 DermWorld print rate card. Download a PDF of the DermWorld print specifications . ... BW ... 1x ... 6x ... 12x ... 24x ... 36x ... Full page ... $3,185 ... $3,015 ... $2,760 ... $2,440 ... $2,350 ... Full
Optimizing prior authorization documentation
Answers in Practice ... By Swapna Bhatia, MPH, December 1, 2020 Each month DermWorld ... tackles issues "in practice" for dermatologists. This month Swapna Bhatia, MPH, the Academy’s health technology and informatics manager, explains prior authorization optimization. Do you know everything that prior authorizations entail? Have prior authorization requirements increased
2024 AAD Innovation Academy | Official exhibitor suppliers
Experient) is the official housing provider for the 2024 AAD Innovation Academy Meeting in Seattle, WA
AADA hosts 10th annual Capitol Hill Skin Cancer Check and Health Fair
Moving the needle ... By Apoorva Stull, Senior Manager, Advocacy Communications, May 1, 2024 DermWorld ... breaks down the latest highlights of AADA advocacy activities at the federal and state legislative and regulatory level. On May 15, the AADA hosted its 10th annual Capitol Hill Skin Cancer Check and Health
Taking the challenge: Social media, adolescents, and the skin
By Albert C. Yan, MD June 12, 2019 Vol. 1, No. 14 Patterned skin injury can raise the specter of non-accidental trauma. However, over the past decade or so, striking examples of patterned skin injury have emerged among adolescents and pre-teens that share certain features: these are self-induced voluntarily; the
Eczema and eye disease
Eczema affects more than your skin. Adults with eczema are at a higher risk of developing ocular diseases. ... Eczema and eye disease ... Click to view and download the infographic. ... Download Sources www.healio.com/dermatology/dermatitis/news/online/%7B39cf915c-23d6-49ac-9f37-10f770c50f9e%7D/atopic-dermatitis-associated-with-ocular-disease-risk www.jaad.org/article/S0190-9622(17)30360-2/fulltext More information Eczema Resource Center Adults with eczema should watch for eye problems Help
Psoriasis and diabetes
Psoriasis is not just a skin disease. There is an association between psoriasis, diabetes, and excess weight, perhaps due to a common genetic cause. ... Psoriasis and diabetes ... Click to view and download the infographic. ... Download Sources: https://consumer.healthday.com/diseases-and-conditions-information-37/psoriasis-news-621/psoriasis-tied-to-obesity-type-2-diabetes-710380.html www.healio.com/news/primary-care/20160822/pcps-should-be-aware-of-potential-psoriasis-risks-treatment-options More information: Psoriasis Resource Center Help and Chat
Advocacy Update Feb. 4 2025
IN THIS ISSUE / Feb. 4, 2025 Physician champions introduce Medicare physician payment fix in House Academy joins coalition urging less regulatory burdens in Medicare Advantage and Part D program AADA urges CMS to improve MVP framework Become an AADA Advocacy Key Contact Support dermatology champions in Congress through SkinPAC
AESOP: The ants and the grasshopper
By Warren R. Heymann, MD, FAAD Aug. 21, 2024 Vol. 6, No. 34 Unquestionably, AESOP ( ... A denopathy and ... E xtensive ... S kin patch ... O verlying a ... P lasmactyoma) is rare — to date, fewer than 25 cases have been reported. (1) Why write (or
APACHE no more
By Warren R. Heymann, MD Dec. 4, 2017 ... A, Dark red, linear plaque on posterior area of right lower leg. B, Slightly raised, scaly, undulating lesion measuring 50 × 12 mm. ... Credit: ... JAAD This commentary is about being DC (Dermatologically Correct), not PC (Politically Correct as in
What is the minimum I need to report to meet the MIPS threshold in 2019?
Asked and Answered ... February 1, 2019 If you or your practice must participate in the Merit-based Incentive Payment System (MIPS) for 2019 and want to simply avoid the ... 7% penalty (penalty applied in 2021), the ... minimum score to avoid the penalty is 30 points — up from
PDF of Eponyms in dermatology
Congenita (dyskerin) easily separated when pressed firmly foliaceous confined to seborrheic sites with a sliding
The congenital perineal groove: Defective recognition of a dermal defect
By Warren R. Heymann, MD ... Feb. 28, 2018 ... It has been nearly half a century since Stephens first detailed the perineal groove (PG) as a congenital malformation consisting of three features: (1) a wet groove in the midperineum between the fourchette and the anus; (2) normal formation of
October 28, 2020
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / October 28, 2020 ... Drug may offer prolonged improvement in chronic spontaneous urticaria DermWorld Insights and Inquiries : Looking into the whites of the mouth Why will dermatology experience a 2%
How can I use DataDerm to report for MIPS?
Asked and Answered ... November 29, 2018 DataDerm™ can help you report for all three MIPS categories in 2018: ... Quality Promoting interoperability (PI) Improvement activities (IA) Here’s how to get started: ... 1. Step one: Sign up. ... Complete the sign-up portal at ... https://dataderm.aad.org/signup/Login.aspx by ... Dec. 7,
2022 DW Insights and Inquiries archive
Explore ... DermWorld Insights and Inquiries articles by publication date. ... December ... Dec. 28 - 2022: Best of DermWorld Insights and Inquiries Dec. 21 - Holiday Greeting 2022 Dec. 14 - A Frank discussion about earlobe creases Dec. 7 - Xylazine ("Tranq"): The potential for loss of life and
Intralesional triamcinolone for hidradenitis suppurativa and thoughts on confirmation bias
By Warren R. Heymann, MD Dec. 2, 2016 Anyone who has treated the scourge of hidradenitis suppurativa (HS) has probably injected inflamed nodules and cysts with triamcinolone (TAC) successfully, resulting in very grateful patients. Despite the useful advent of adalimumab to the other (less than satisfactory) modalities of antibiotics,
The profound dermatological manifestations of COVID-19 Part VI: Going to the dogs
By Warren R. Heymann, MD July 29, 2020 Vol. 2, No. 30 Disclaimers: This commentary was written on July 12, 2020 for a publication date of July 29, 2020. The issues related to the COVID-19 pandemic are changing rapidly. The content included in this commentary may no longer be factual
Changes to the Placement of Modifiers Starting on July 1st
On July 1, 2019, the Centers for Medicare and Medicaid Services National Correct Coding Initiative (CMS/NCCI) Procedure-to-Procedure (PTP) Edits, Version 25.2 will go into effect. The MLN Matters Number: MM11227 (CR 11227) released on March 29 announced the release of the 2019 third quarter updates to the NCCI/PTP edits. ...
Tarrying for tapinarof
By Warren R. Heymann, MD, FAAD January 12, 2022 Vol. 4, No. 2 Today we held our first round of interviews for our dermatology residency program for 2023. Meeting dermatology resident applicants is a delight — they are brilliant, engaging, and a source of pride for our discipline. We started
Short duration cyclosporine may undress DRESS
By Warren R. Heymann, MD July 22, 2016 DRESS (Drug Rash with Eosinophilia and Systemic Symptoms) is a severe drug-induced hypersensitivity syndrome (DIHS) that may affect adults and children. The eruption of DRESS usually appears 3 weeks to 2 months after introduction of the drug. The rash is primarily morbilliform,
Playing the field: Introducing tirbanibulin for actinic keratosis therapy
By Warren R. Heymann, MD January 27, 2021 Vol. 3, No. 4 Field therapy is a cornerstone of actinic keratosis (AK) management. Two years ago, a ... New England Journal of Medicine article demonstrated that 5-fluorouracil (5-FU) was the best among inadequate therapies (compared to imiquimod, MAL-PDT, and ingenol mebutate).
What challenges and barriers exist when patch testing children?
Clinical Applications ... Dr. Schwarzenberger is the former physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, June 1, 2021 In this month’s Clinical Applications column, Physician Editor Kathryn Schwarzenberger, MD, talks with JiaDe (Jeff) Yu, MD, about
CareCredit
An AAD preferred provider since 2012, CareCredit is a health, wellness, and personal care credit card that helps patients fit dermatology care into their health care budget, with promotional financing options that allow them to pay over time. ... 1 ... CareCredit celebrates 35+ years of helping patients move forward
Men in the Twilight Zoon
By Warren R. Heymann, MD February 19, 2020 Vol. 2, No. 7 It is a dimension as vast as space and as timeless as infinity. It is the middle ground between light and shadow, between science and superstition, and it lies between the pit of man's fears and the summit
Treating metastatic melanoma: Understanding a brave new world
Acta Eruditorum ... Dr. Schwarzenberger is the former physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, April 2, 2018 In this month's Acta Eruditorum column, Physician Editor Kathryn Schwarzenberger, MD, talks with Jane Grant-Kels, MD, and Daniel
Spot on! Lentigines in resolved psoriatic plaques
By Warren R. Heymann, MD Nov. 30, 2016 Having treated psoriatic patients throughout my career, there have been innumerable occasions where patients were concerned about pigmentary changes following successful treatment of the plaques. I have usually reassured them that these are postinflammatory pigmentary alterations that should abate with time. Recently,
What is quality improvement
What is Quality Improvement? ... Quality Improvement (QI) consists of systematic and continuous actions that lead to measurable improvement in health care services and the health status of targeted patient groups ... 1 ... . The Institute of Medicine identifies six dimensions of health care quality that can be used
Trichophyton rubrum resistant to terbinafine
Trichophyton rubrum resistant to terbinafine ... T. rubrum , a dermatophyte fungus, is the most common cause of dermatophytosis worldwide. ... 1 ... Oral terbinafine is considered a first-line treatment for most infections caused by this fungus, but cases of terbinafine-resistant ... T. rubrum are increasingly being reported worldwide and
Understanding the risk of Wilms Tumor in hemihypertrophy: Are we halfway there?
By Warren R. Heymann, MD Nov. 16, 2017 ... Diffuse capillary malformation with overgrowth. A 2-month-old girl with ill-defined erythematous patches of the bilateral upper extremities, posterior trunk, and left lower extremity. There is also overgrowth of the left lower extremity. ... Credit: ... JAAD Wilms tumor (WT, nephroblastoma) is
Collodion babies and endocrine disorders: Another concern
By Warren R. Heymann, MD June 23, 2017 Collodion baby. Tight, shiny film or dried collodion reminiscent of the skin of a sausage covers the entire surface of this 2-day-old neonate whose mother was treated with infliximab throughout her pregnancy. ... Credit: ... JAAD Collodion baby (CB) describes an infant
Life insurance 102: Five success factors when using permanent life insurance
Money Matters ... David B. Snyder, JD, CLU ... ® ... , is an attorney, author, and financial advisor at the wealth management firm OJM Group. He covers financial issues for dermatologists in this quarterly ... Dermatology World column. ... By David B. Snyder, JD, CLU, September 2, 2019 In
Yeast rising: Predicting the efficacy of candida antigen immunotherapy for warts
By Warren R. Heymann, MD Oct. 2, 2017 ... Numerous flat warts (verrucae plana) seen on upper extremities of patient with epidermodysplasia verruciformis. ... Credit: ... JAAD Perhaps I’m paranoid, but I always think that warts are laughing at me, or at least at whatever I throw at them —
All awards, grants, and scholarships by American Academy of Dermatology
The Academy bestows a number of prestigious awards to recognize the contributions of individuals to the specialty as well as offering various grants and scholarships to assist recipients in furthering their areas of study and broadening knowledge in the field of dermatology. ... Awards ... Name ... Application opens ...
Reduce Drug Code Denials Related to Incomplete Claims Data
Claim denials for drug supplies are often the result of improper national drug codes (NDC) format or missing information related to the drug provided—vital information that is needed by the payer to appropriately adjudicate the claim. ... Physician claims for drugs supplied in the office must include the 11-character NDC
Covfefe and the art of the diagnostic deal
By Warren R. Heymann, MD June 2, 2017 Progressive nodular histiocytosis. A, Multiple papulonodular lesions over upper extremities and trunk. B, Leonine appearance for coalescing of lesions on face. ... Credit: ... JAAD I don’t know what’s more frightening — making diagnoses on autopilot or being genuinely stumped and having
An incisive approach to chronic paronychia: The square flap technique
By Warren R. Heymann, MD Aug. 2, 2016 I cannot begin to guess how many patients I have seen with chronic paronychia (CP) since I started my residency 36 years ago. I know precisely how many patients I have referred for surgical correction of CP — zero! The reason for
2022: Best of DermWorld Insights and Inquiries
December 29, 2022 We know how much you enjoy Dr. Heymann and the editorial board’s weekly analyses of dermatologic literature, so we’ve created a list of the top 10 most popular issues in 2022 — starting with the most popular issue of the year. ... 1. Coming full circle (almost)
Mogamulizumab for CTCL: Targeted therapy and immunotherapy crossing paths
By Ellen Kim , MD August 12, 2020 Vol. 2, No. 32 Preserving the host-immune system for as long as possible has been one of the guiding principles for me in treating patients with mycosis fungoides/Sezary Syndrome (MF/SS) subtypes of CTCL. As a CTCL clinical trial researcher, it has been
Homing in on hornerin: Breaking down the barrier to understand its crucial role in atopic dermatitis
By Warren R. Heymann, MD, FAAD Oct. 16, 2024 Vol. 6, No. 42 Atopic dermatitis (AD) is characterized by skin barrier dysfunction, inflammation, and chronic pruritus. The etiology of AD, however, is complicated and incompletely understood, with genetic, environmental (soaps, surfactants, stress), and immunological factors causing skin barrier abnormalities and
Giving a NOD2 to Yao syndrome
By Warren R. Heymann, MD, FAAD March 5, 2025 Vol. 7, No. 9 The 21 ... st century has witnessed an expanding array of systemic autoinflammatory disorders (SAIDs) due to innate immunity dysfunction. SAIDs are characterized by recurrent attacks of fever, cutaneous signs, chest or abdominal pain, lymphadenopathy, vasculopathy, and
Spironolactone: An increasingly recognized hero in acne therapy
By David A. Wetter, MD July 1, 2020 Vol. 2, No. 26 In 1983, Bonnie Tyler released the catchy and powerful anthem, "Holding Out for a Hero." Emotion exudes from the lyrics: ... I need a hero I’m holding out for a hero ‘til the morning light He’s gotta be
Can topical ketoconazole tip the scales for acne vulgaris?
By Warren R. Heymann, MD Oct. 21, 2020 Vol. 2, No. 42 "Now trending." How often have you seen that phrase when you go online? When it comes to trends in treating acne vulgaris (AV), despite the new addition of oral sarecycline and the release of topical minocycline foam, there
Clinical information
1. How contagious is measles? ... Measles is a highly contagious virus, much more contagious than the common cold and even more contagious than other outbreaks like smallpox or Ebola. ... 1 ... Measles is potentially transmissible even after brief exposures and at distances up to 30 meters. ... 2
Long COVID has a lot of nerve
By Warren R. Heymann, MD, FAAD Dec. 17, 2025 Vol. 7, No. 49 The profound medical and socioeconomic trauma of the COVID-19 pandemic may seem as though it is in the rearview mirror, but it is not. As of April 15, 2025, the CDC estimated that COVID-19 infections are growing
Focusing attention on X-linked ichthyosis
Ichthyosis vulgaris ... Credit: ... JAAD By Warren R. Heymann, MD Jan. 2, 2019 I thought it was me. Like every dermatologist, I learned the classical appearance of the ichthyoses, and wonder why I’m not sure if I am looking at a patient with ichthyosis vulgaris (IV) or X-linked ichthyosis
COVID-19 can nail you in so many ways
By Elizabeth Yim, MD, MPH, FAAD, and John Montgomery Yost, MD, MPH, FAAD July 13, 2022 Vol. 4, No. 28 Dr. Elizabeth Yim and Dr. John M. Yost. ... During these difficult and quite frankly, scary times, we have heard numerous reports of various cutaneous manifestations by the SARS-COV-2 infection
Becoming “sensitized” to the clinical utility of the term “urticarial dermatitis” (a subtype of the dermal hypersensitivity reaction pattern)
By David A. Wetter, MD, FAAD April 2, 2025 Vol. 7, No. 13 I suspect many of us have been confounded when confronted with a patient presenting with cutaneous findings suggestive of a "dermal hypersensitivity reaction." What is the cause? How should it be evaluated and treated? What do we
Pityriasis rubra pilaris: Check a TSH!
By Warren R. Heymann, MD ... June 10, 2016 ... There are myriad ways to mine the data from the review of 100 cases of PRP by Ross et al, however, one key finding will change the way I will assess these patients — 20% were hypothyroid! (1) ... There
March 31, 2021
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / March 31, 2021 ... Studies show skin rashes are highly predictive of positive COVID-19 results DermWorld Insights and Inquiries : Netherton syndrome — From apex to nether New AAD research grant
Parabens — A common allergen with lots of hype and no real harm
By Christen M. Mowad, MD Sept. 4, 2019 Vol. 1, No. 26 Every year for the past 20 years, the American Contact Dermatitis Society (ACDS) has highlighted an allergen. Most often the particular allergen is selected because it is new and emerging, such as methylisothiazolinone in 2013. (1) Sometimes, it
Sirolumus’s merit for the Kasabach-Merritt phenomenon
By Warren R. Heymann, MD Oct. 8, 2018 KHE patient after 15 months of sirolimus therapy. ... Credit: ... JAAD Thrombopenic purpura associated with benign hemangioma is rare. In fact, we have not been able to find a record of a combination of these two conditions in the medical literature.
2020 DW Insights and Inquiries archive
Explore ... DermWorld Insights and Inquiries articles by publication date. ... December ... December 23 - 2020 holiday greeting December 16 - We’re in hot water! Vibrio vulnificus infections are heading north December 9 - Much ado about nothing in dermatopathology December 2 - Pigmented onychomatricoma: Avoid getting nailed by
Necrotizing infundibular crystalline folliculitis: Not yet crystal clear
By Warren R. Heymann, MD, FAAD Jan. 29, 2025 Vol. 7, No. 4 Time and exposure to several articles are necessary to crystallize a novel clinicopathological correlation in my mind. Such is the case with necrotizing infundibular crystalline folliculitis (NICF). I suspect that I have seen this condition but have
Primary sclerosing cholangitis associated with pyostomatitis vegetans and pyodermatitis vegetans: A potentially bilious situation
By Warren R. Heymann, MD Aug. 29, 2016 Inflammatory bowel disease may be associated with multiple cutaneous manifestations including pyoderma gangrenosum (PG), erythema nodosum, or directly by fistulae or "metastatic" Crohn disease. Seven cases of pyostomatitis vegetans-pyodermatitis vegetans (PSV-PDV) were reviewed. All 7 patients had inflammatory bowel disease (IBD) —
Difficulty differentiating palmar psoriasis from eczema: Can dermatopathologists lend a Hand?
By Warren R. Heymann, MD July 2, 2017 Clinical manifestations of palmar skin lesions. A, Palmar psoriasis appeared as scattered hyperkeratotic scaly round patches over the entire palm. B, Hand eczema appeared as scaly patches on the palm and phalanges. C, Hyperkeratotic hand dermatitis appeared as sharply demarcated areas of
PDF of Retinoid biology part 2
boards’ fodder Review of Retinoid Biology: Part 2 Mariana Phillips, MD.
Taking psoriasis by the throat
By Warren R. Heymann, MD Nov. 2, 2016 Once the transient satisfaction of explaining the association of streptococcal infections with psoriasis (guttate, vulgaris, or pustulosis palmaris et plantaris) passes, the reality of treatment must be addressed. Of course we’ll prescribe the usual regimens — topical steroids, phototherapy, retinoids, biologics, etc.,
Dermatomyositis oddities: Could one be responsible for the other?
By Warren R. Heymann, MD Sept. 19, 2016 So much about dermatomyositis (DM) has intrigued me since medical school. Over the years, I have probably read more about this disease than any other malady. I am always amazed how I much more there is to learn. ... There were two
Weighing in on glucagon-like peptide-1 receptor agonists in dermatology
By Warren R. Heymann, MD, FAAD April 17, 2024 Vol. 6, No. 16 Glucagon-like peptide-1 (GLP-1) receptor agonists — your patients are on them, and perhaps you are too (or at least have thought about it). In 2023, more than 500 million people worldwide were afflicted with obesity and type
June
Issue ... June January February March April May June July August September October November December View digital flipbook In this issue ... From the Editor ... From the editor What's hot ... What's hot? Cracking the Code ... Components of evaluation and management 2 Acta Eruditorum ... New urticaria guidelines
Bowel-associated dermatosis-arthritis syndrome (BADAS): The story behind the acronym
By Warren R. Heymann, MD, FAAD March 30, 2022 Vol. 4, No. 13 Justifiably, the COVID-19 pandemic has focused the world’s attention, however, another global pandemic threatens us — obesity. According to the World Health Organization, in 2016, more than 1.9 billion people are overweight (BMI > 25) and 650
A point to make about punctate, pigmented, and verrucous papillomatosis
By Warren R. Heymann, MD July 25, 2016 What is your mental image of the Gougerot-Carteaud (GC) syndrome? I equate it with confluent and reticulated papillomatosis, presenting on the trunk with hyperpigmented minimally raised plaques. The KOH examination is negative and there is a quick, characteristic response to antibiotics such
October
Issue ... October January February March April May June July August September October November December View digital flipbook In this issue ... From the Editor ... This year, the ADA celebrates its 30th anniversary What's hot ... This month's news from across the specialty Clinical Applications ... What role can
Studying skin aging never gets old: The potential role of oxytocin
By Warren R. Heymann, MD Oct. 14, 2020 Vol. 2, No. 41 Every day, dermatologists address patient concerns about their aging skin — whether they are presenting for medical, surgical, or cosmetic problems. Extrinsic factors such as ultraviolet light and smoking resulting in a leathery, coarsely wrinkled appearance are well
Advisory Board Call for Nominations: Someone you know
At the close of the 2026 annual meeting, there will be one seat open on the Advisory Board Executive Committee (ABEC). This is a great opportunity to become more involved in your Advisory Board! ... The in-person election will be held on Sunday, March 29, 2026, at 2:00 p.m. MT,
2026 AADA Legislative Conference
Save the date for the 2026 AADA Legislative Conference, held September 13-15 in Washington, D.C. ... Weren't able to attend the 2025 Legislative Conference? ... Catch up on the sessions in the AAD Learning Center. ... Get Started When ... Sept. 13-15, 2026 ... Where ... J.W. Marriott ... 1331
Advisory Board news
Parliamentary procedures at a glance ... Review a PDF of parliamentary procedures . ... Upcoming Advisory Board meetings ... Advisory Board Reference Committee Hearing ... Colorado Convention Center, Rooms 601-603 ... Friday, March 27, 2026 ... 1:00-3:00 p.m. MT ... Advisory Board General Business Meeting ... Colorado Convention Center, Rooms
Pseudomolluscoid papules: A more accurate description than pseudoverrucous papules
By Warren R. Heymann, MD April 28, 2016 When patients ask me how I made their diagnosis so quickly, I politely tell them that if any particular lesion takes more than 25 milliseconds to diagnose, they really do have a problem. ... Today I saw a patient that made me
The profound dermatological manifestations of COVID-19: Part V – Pediatric multisystem inflammatory syndrome
By Warren R. Heymann, MD May 13, 2020 Vol. 2, No. 19 Disclaimers: This commentary was written on May 7, 2020 for a publication date of May 13, 2020. The issues related to the COVID-19 pandemic are changing by the millisecond. The content included in this commentary may no longer
Provider to Patient Exchange objective
Measure: Provide Patients Electronic Access to their Health Information (PI_PEA_1) ... DESCRIPTION For at least one unique patient seen by the MIPS EC: 1) the patient (or patient-authorized representative) is provided timely access to view online, download, and transmit his or her health information; and 2) the MIPS EC ensures
Twenty-first century pellagra
By Warren R. Heymann, MD, FAAD Sept. 10, 2025 Vol. 7, No. 36 With obesity (defined as a body mass index > 30) affecting more than 40% of the adult population of the United States (1), it is difficult to fathom that nutritional deficiencies still exist. Kiani et al. expertly
Dupilumab treatment of bullous pemphigoid: Hoping for approval on the double
By Warren R. Heymann, MD, FAAD Jan. 15, 2025 Vol. 7, No. 2 Perhaps dupilumab won’t be the game-changing biologic that patients are pining for. At the least, it represents the dawn of the biologic era for AD [atopic dermatitis] ... . That alone offers hope for our long-suffering patients,
Unmasking the complications of personal protective equipment
By Christen Mowad, MD August 5, 2020 Vol. 2, No. 31 Allergic contact dermatitis and irritant contact dermatitis have long been identified as potential adverse reactions to personal protective equipment (PPE) most commonly due to gloves. The global pandemic caused by COVID-19 has heightened the need to use PPE as
Methotrexate toxicity: What’s in a name?
By Warren R. Heymann, MD Aug. 24, 2017 Methotrexate-induced skin toxicity: photographs of 4 illustrative cases. A, Erosions in psoriatic plaques over the torso (patient 1). B and C, Ulcerated and reticulated psoriatic plaques over the arms (patient 2). D, Small shallow cutaneous erosions (patient 4). E, Mucosal erosions over
When to see red in linear erythronychia — Malignant onychopapilloma
By Warren R. Heymann, MD, FAAD June 29, 2022 Vol. 4, No. 26 With every passing year, I take increasing comfort in the stability of the linear erythronychia of my left fifth digit. The presumed diagnosis of an onychopapilloma (OP) is very reassuring because every article I ever read about
Beyond disfigurement: The potential for keratinocyte carcinoma in discoid lupus erythematosus
By Warren R. Heymann, MD, FAAD Jan. 10, 2024 Vol. 6, No. 2 Cosmetic disfigurement due to scars and dyspigmentation is the main complication of discoid lupus erythematosus (DLE). The current classification of cutaneous lupus erythematosus (CLE) includes acute cutaneous LE (ACLE), subacute LE (SCLE), chronic cutaneous LE (DLE, LE
Here comes summer (and sunscreen conversations)!
By Warren R. Heymann, MD April 29, 2020 Vol. 2, No. 17 As the summer solstice approaches, days will lengthen, as will patient-related conversations regarding sunscreen use. In this anxiety-ridden age, with all the information overload, patients’ questions have expanded beyond what sunscreen we recommend. Concerns for safety — both
Reflections on infantile perianal pyramidal protrusion and Hippocrates
By Warren R. Heymann, MD, FAAD May 29, 2024 Vol. 6, No. 22 Patient safety and quality improvement have been at the forefront of medical care since the publication of "To Err is Human: Building a Safer Health System" by the Institute of Medicine, which estimated that as many as
Trichophyton indotineae infections and other severe or antifungal-resistant dermatophytoses
Dermatophytosis (ringworm, tinea, jock itch, athlete’s foot) is a very common and typically minor infection of the skin caused by dermatophyte fungi. ... 1 ... In the past decade, severe or antifungal-resistant dermatophytoses have become a global public health concern, including in the United States. ... The AAD has assembled
Bank of America - Practice Solutions
When you need financing for your dermatology practice, you want to work with someone who understands your industry. For over 25 years, Bank of America Practice Solutions has helped dermatologists across the nation reach their goals through smart financial solutions ... 1 ... and expert guidance. Whether you own a
DWI&I Holiday Greeting 2023
By Warren R. Heymann, MD, FAAD Dec. 20, 2023 Vol. 5, No. 50 Dear ... DWI&I Devotee: ... I always look forward to writing my annual holiday greeting, but admittedly, doing so this year has been a source of angst and consternation. The past few years have been about the
Is there a best approach to widespread actinic keratoses?
By Deirdre Connolly, MD and Naomi Lawrence, MD April 10, 2019 Vol. 1, No. 5 Journal of the American Academy of Dermatology Volume 72, Issue 2, Pages e57-e59 (February 2015) ... Widespread actinic keratoses (AKs) are problematic to both patients and physicians, not only because of their pre-cancerous nature, but
Yom Kippur and the physician payment Sunshine Act
By Warren R. Heymann, MD Oct. 9, 2016 Yom Kippur, the Jewish day of atonement, is upon us. It is Judaism’s most sacred holiday. It is a day of fasting and prayer to atone for sins of the past year. According to traditional teachings, a person’s fate is written in
LIDA* rose the insulin requirement
By Warren R. Heymann, MD April 14, 2021 Vol. 3, No. 15 * Localized insulin-derived amyloidosis ... Amyloidosis, I thought I knew ye. But alas, you fooled me again. ... Amyloid is an insoluble protein folded in ... β -pleated sheets that is deposited extracellularly. Amyloid can accumulate in one
Dermatology practice staff by the numbers
Facts at your Fingertips ... By Emily Margosian, July 2, 2018 Nurses, aestheticians, billers — who’s most likely to be spotted working in the average dermatology practice? Aside from dermatologists, medical assistants and practice administrators are the most widely employed across all practice settings, according the 2017 AAD Practice Profile
AADA Advocacy Win: CMS suspends CLIA lab director enforcement policy
June 23, 2025 Advocacy News Alert As a direct result of advocacy by the AADA, CMS will exercise enforcement discretion on several provisions of its revised CLIA laboratory director policy that had excluded board-certified dermatologists from directing moderate- and high-complexity laboratories. Specifically, CMS will: ... Allow for individuals qualified as
Becoming whipped up over flagellate dermatoses
By Warren R. Heymann, MD ... July 13, 2017 ... A, A 44-year-old male patient with characteristic flagellate dermatitis after ingestion of shiitake. B, Same patient 4 days after balneo PUVA therapy. ... Credit: ... JAAD The literature on flagellate dermatoses has been whipped into frenzy. The initial description
Reopening the dermatologic surgery office in the COVID-19 era
By Ashley Decker, MD, Henry Heaton, MD, and Naomi Lawrence, MD May 20, 2020 Vol. 2, No. 20 Authors Ashley Decker, MD, Naomi Lawrence, MD, and Henry Heaton, MD, wearing PPE. ... The coronavirus disease 2019 (COVID-19) presents extraordinary challenges to the health care community, including dermatology and dermatologic surgery.
Cutting giant congenital nevi down to size molecularly
By Warren R. Heymann, MD Oct. 2, 2019 Vol. 1, No. 30 Personally, I find giant congenital melanocytic nevi (GCMN) to be among the most unnerving skin lesions imaginable. The risk of melanoma, leptomeningeal melanocytosis, and psychosocial stresses are profoundly burdensome to patients, their families, and health care professionals. With
Striving to alleviate the physical and emotional scars of central centrifugal cicatricial alopecia
By Warren R. Heymann, MD November 4, 2020 Vol. 2, No. 44 More than half a century ago, Drs. Lopresti, Papa, and Kligman coined the term "hot comb alopecia," asserting: "The cause is unmistakable, namely the practice of straightening the hair with a hot comb…" (1). Now known as central
'Stepping up' to off-label dosing of biologics
By David A. Wetter, MD, FAAD April 6, 2022 Vol. 4, No. 14 It is an exciting time to be a medical dermatologist, with the ongoing development of numerous safe and effective systemic treatments for several complex medical dermatologic diseases. For example, both the American and British guidelines for the
How can I get a receipt for payments made to the Academy?
Asked and Answered ... March 1, 2020 For all Academy-related payments — membership dues, past orders, a subscription to ... Dialogues in Dermatology — AAD members can access their receipts as follows: ... 1. Visit ... www.aad.org/members 2. Sign in to your member profile ... 3. Click the "Account" tab
Transplantation dermatology: Race matters
By Warren R. Heymann, MD June 21, 2017 African American man with generalized vitiligo. Medial aspect of foot before (A) and 5 months after (B) melanocyte-keratinocyte transplantation procedure. ... Credit: ... JAAD December 3rd, 2017 will mark the 50th anniversary of the first human-to-human heart transplant performed by the late
Health Information Exchange
Important note: Do not report on all three options ... For this objective, you may choose to report data for: ... The two existing HIE measures, ... or The HIE Bi-Directional Exchange measure, ... or The Enabling Exchange Under TEFCA measure. ... Measure: Support Electronic Referral Loops by Sending Health
August 20, 2025
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Aug. 20, 2025 ... Oral vs. topical finasteride: Sexual, neuropsychiatric AEs DermWorld Insights and Inquiries : Sweating over sweat gland carcinomas: Part 2 — Eccrine mucin-producing sweat gland carcinoma Are topical
July 27, 2022
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / July 27, 2022 ... Facial hyperhidrosis: Botulinum toxin A injection vs. topical glycopyrrolate DermWorld Insights and Inquiries : JAKne is on the horizon Dupilumab for chronic prurigo, chronic idiopathic pruritus Safety
PDF of Histiocytosis
X) Letterer–Siwe Young infants Scalp, face trunk, but- • Visceral and bone More epidermotropism, (<2
Academic Dermatology Leadership Program (mentee)
The Academic Dermatology Leadership Program (ADLP) is a comprehensive program that requires a full-year commitment. ... Applications for the 2027 Academic Dermatology Leadership Program will open July 2026 ... Please send me an email reminder when the application opens . ... By applying for this program, you are agreeing to
Improvement activities (15%)
In this performance category, clinicians are rewarded for care focused on care coordination, beneficiary engagement, and patient safety. For 2025 MIPS reporting, this category is worth 15% of the MIPS score with a maximum of 40 points available. There are 77 dermatology-relevant practice improvement activities (IAs) to choose from. ...
Congress must act to protect patients’ health care access
Statement from Terrence A. Cronin Jr., MD, FAAD, President of the American Academy of Dermatology Association WASHINGTON (Nov. 2, 2023) — CMS finalized cuts to the physician fee schedule for 2024, which will impact the ability of medical practices to cover expenses like equipment, rent, and nursing and office staff
Juvenile lichen sclerosus: A loss of innocence
By Warren R. Heymann, MD August 19, 2020 Vol. 2, No. 33 Juvenile lichen sclerosus (LS) is a difficult disorder — symptomatically, emotionally, diagnostically, and therapeutically. During my residency it was "common knowledge" that juvenile LS would abate by adolescence. I am always curious how such perceptions become dogma, only
Cellular neurothekeoma: A tribute to Barnhill and Mihm and a remembrance of Martin C. Mihm Jr., MD
By Warren R. Heymann, MD, FAAD Aug. 2, 2023 Vol. 5, No. 31 The profound sense of loss prompting people to endure waiting over 24 hours in a queue to pay their final respect to Queen Elizabeth II at Westminster Hall was an astonishing sight last year. The overwhelming majority
Speculating on spicules: Our incomplete knowledge of trichodysplasia spinulosa
By Warren R. Heymann, MD, FAAD December 15, 2021 Vol. 3, No. 49 For inexplicable reasons, there are certain differential diagnoses that I find particularly satisfying, one being disorders responsible for facial follicular spicules: follicular mucinosis (1), pityriasis folliculorum ... (Demodex folliculorum) (2), follicular hyperkeratotic spicules (myeloma immunoglobulin or cryoglobulin)
The pregnant pause in cutaneous lymphoma
By Jennifer Villasenor-Park, MD, FAAD Oct. 2, 2024 Vol. 6, No. 40 I first met Anne when she was 30 years old and was experiencing a significant flare of her mycosis fungoides. She had already lived with the disease for 18 years having been diagnosed at the age of 12
Atopic dermatitis hide and seek: The impending role of OX40 inhibition
By Warren R. Heymann, MD, FAAD Sept. 11, 2024 Vol. 6, No. 37 The burden of atopic dermatitis (AD) — for patients, their families, and society — is vast and increasing. AD affects approximately 10% to 30% of children and 2% to 10% of adults in developed countries. (1) Aside
When ads subtract
By Warren R. Heymann, MD Aug. 2, 2018 "Could the skin lesion you’re seeing…actually be a deadly blood cancer?….Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive and deadly hematologic cancer with skin lesions that may be mistaken for other skin disorders…When biopsying skin lesions, ask your pathologist to test
Thoughts about genital melanosis on Melanoma Monday
By Warren R. Heymann, MD May 1, 2017 Vulvar genital melanosis. The lesions on the posterior fourchette are dark brown to black in color while other superior macules in the labia minora and vagina are lighter brown. Additively, the lesions are more than 2 cm in diameter. The lesions are
Viva ex vivo dermoscopy?
By Warren R. Heymann, MD March 12, 2017 Evaluation of dermoscopic features on a formalin-fixed specimen (ex vivo dermoscopy) using a smartphone attached to a dermoscope. ... Credit: ... JAAD It has been said that the best "special stain" is a deeper section — wise words indeed. While always gratifying
Truth in advertising pathways
As AAD members identify examples of advertisements in their community that could mislead patients to believe they are receiving care from a dermatologist, the AAD has developed template letters for its members to contact the licensing board that regulates such individual. ... Scenario #1: A non-dermatologist physician holds oneself out
Looking beyond ‘Ozempic face’
Dermatologists weigh in on cutaneous side effects of GLP-1 agonists. ... Feature ... By Emily Margosian, Senior Editor, November 1, 2025 Glucagon-like-peptide-1 (GLP-1) agonists are an emerging class of medications used to manage type 2 diabetes mellitus (T2DM) and weight loss, with demonstrated efficacy in reducing hemoglobin A1c levels, body
AAD | Prior Authorization Resources
The following resources are to assist physicians, medical staff, and patients effectively navigate through prior authorizations. ... Prior authorization podcast ... Download ... Practice Management Series: Prior Authorization: What a Pain! a podcast with John Barbieri, MD, MBA, FAAD, interviewed by Khang Nguyen, MD, FAAD. ... Prior authorization guidelines for staff
Lichenoid and granulomatous dermatitis: Points to ponder
By Kiran Motaparthi, MD June 10, 2020 Vol. 2, No. 23 Clinical-pathologic correlation is the foundation of dermatologic diagnosis; often this is straightforward, but on occasion, getting to the precise diagnosis requires great thought and sleuthing. If you receive a report from your dermatopathologist with a descriptive diagnosis of "lichenoid
Develop a nose for suspecting angiosarcoma
Angiosarcoma histopathology. Anastomosing dilated vessels, lined by crowded endothelial cells, extend between pre-existing collagen bundles. (Hematoxylin-eosin-saffron stain; original magnification: ×40.) ... Credit: ... JAAD By Warren R. Heymann, MD Nov. 12, 2018 Occasionally I read an article that disturbs me, because I know that I would miss the diagnosis, with
Why you should hear about the red ear syndrome
By Warren R. Heymann, MD July 22, 2020 Vol. 2, No. 29 Is it my imagination that the "by the way" comments at the presumed end of a patient encounter cause the most angst? Usually, it’s something like "Oh, I forgot to mention that I’m losing my hair!" Recently, at
Digging deeper into lupus erythematosus panniculitis
By Warren Heymann, MD May 5, 2021 Vol. 3, No. 18 Lupus erythematosus panniculitis (aka lupus erythematosus profundus, LEP) has a storied history. The famed clinician Harry Arnold noted that Kaposi (when he was Kohn) observed nodules in patients with lupus. (1) Debates and controversies ensued for decades, with many
PRIDE without prejudice
By Warren R. Heymann, MD, FAAD July 30, 2025 Vol. 7, No. 30 As the years march on, I am bemused by having witnessed once-novel findings become mainstream affairs. I recall my excitement describing the development of paronychia in a 76-year-old woman with metastatic colon carcinoma who was participating in
Turning our attention to melanoma risk in Turner syndrome
By Warren R. Heymann, MD, FAAD July 2, 2025 Vol. 7, No. 26 "…at the endocrine clinic and in private practice, I had seen a few young girls who had not matured, and they were short in stature and they had short necks with a low hair line and increased
PDF of Oral disease, part 2
boards’ fodder #1 Oral Disease, Part 2 by Helena Pasieka, MD CLINICAL PATHOLOGY TREATMENT ASSOCIATIONS
2026 AAD Annual Meeting: Donor Lounge
The AAD Donor Lounge is located in Room 107/109 in the Colorado Convention Center. The lounge will be open Friday, March 27 through Monday, March 30 during the hours listed below. Stop by and take advantage of a place to relax during the meeting, enjoy coffee or a bite, and
How do I apply for a CLIA certificate?
There are two options available to physicians when applying for a CLIA certificate: ... Option 1 ... Go through your state CLIA office and submit appropriate application materials and fees. ... CMS offers contact information for each state . ... Option 2 ... Go through an accreditation agency that certifies
Dupilumab’s growing pains
By Warren R. Heymann, MD January 8, 2020 Vol. 2, No. 1 Dupilumab has been a valuable addition to dermatologists’ therapeutic palette in managing atopic dermatitis (AD). The biologic agent was released in 2017, indicated for moderate to severe AD, and is now approved for patients who are at least
Phacing the future: When patients with PHACE syndrome grow up
By Warren R. Heymann, MD June 24, 2020 Vol. 2, No. 25 The acronym PHACE syndrome, emphasizing the characteristic findings of this neurocutaneous syndrome: ... p osterior fossa malformations, ... h emangiomas, ... a rterial anomalies, ... c oarctation of the aorta and cardiac defects, and ... e ye abnormalities,
Shedding light on tumoral melanosis
By Warren R. Heymann, MD, FAAD Oct. 9, 2024 Vol. 6, No. 41 Tumoral melanosis (TM) is a worrisome and confounding lesion for dermatologists and dermatopathologists alike. TM presents as darkly pigmented macules, papules, or nodules mimicking the appearance of a melanoma. Most cases are associated with either partial or
Topical minocycline for acne: A good Idea?
By Warren R. Heymann, MD May 28, 2016 Concerns about the safety of minocycline have been increasing over the past two decades, with rare, serious adverse immunologic reactions including DRESS syndrome, pneumonitis, nephritis, autoimmune hepatitis, and a lupus-like syndrome (1). There have been several reports of ANCA-positive polyarteritis nodosa (PAN)
The profound dermatological manifestations of COVID-19
By Warren R. Heymann, MD March 18, 2020 Vol. 2, No. 11 Disclaimers: This commentary was written on March 12, 2020 for a publication date of March 18, 2020. The issues related to the COVID-19 pandemic are changing at breakneck speed. The content included in this commentary may no longer
Ultraviolet light, adipose tissue, and fantasies of summer
... By Warren R. Heymann, MD April 2, 2018 As I am preparing this commentary, the second Nor’easter within a week is in its frenzy. (Since that time there have been two more and it’s snowing today!) My longing for summer, enjoying the warm breezes enveloping our shore home
AAD | Tool Drugs and Diseases
See a list of available drugs and dermatologic conditions available in the tool. ... Drug name ... 4% minocycline foam (Amzeeq®) ... Class 2 steroid ... Isotretinoin ... Sulfacetamide sodium-sulfur ... 5-fluorouracil (Efudex®) ... Clobetasaol ... Isotretinoin with enhanced absorption (Absorica®) ... Tacrolimus ointment (Protopic®) ... Abrocitinib (Cibinqo®) ... Corticosteroid
Skin Cancer Awareness Month campaign reaches billions!
May is Skin Cancer Awareness Month, and in 2024 the Academy once again undertook a robust effort to spread awareness to the general public. Similar content did very well in 2022, did even better in 2023, and shows no signs of stopping in 2024! ... During the month, the Academy
Stevens-Johnson Syndrome-Toxic Epidermal Necrolysis: The aftermath
By Warren Heymann, MD May 26, 2021 Vol. 3, No. 21 The American Academy of Dermatology’s SkinSerious ... ® ... campaign highlights how dermatologists treat serious diseases. Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) top the list. (1) Justifiably, all attention focuses on the immediate issues in an attempt
Key messages for social media about hair loss
Key messages ... Many conditions and diseases can result in hair loss, as can improper hair care. ... The most common cause of hair loss is hereditary thinning or baldness, also known as androgenetic alopecia. (1) This condition affects an estimated 80 million Americans — 50 million men and 30
New American Academy of Dermatology survey reveals most Americans say sun protection is more important now than five years ago, yet many misunderstand how to protect themselves
Dermatologists urge the public to protect themselves from the sun to reduce skin cancer risk ahead of Melanoma Monday (May 2) and Skin Cancer Awareness Month ROSEMONT, Ill. (April 26, 2022) — In a recent survey of more than 1,000 U.S. adults, the American Academy of Dermatology found that while
Generalized multinucleate cell angiohistiocytomas and thoughts on diagnostic first impressions
By Warren R. Heymann, MD April 1, 2017 I became aware of multinucleate cell angiohistiocytomas (MCA) when I learned of an article published by friends who reported the first cases in the United States (1). The following abstract by Smolle et al (2) accurately described the entity, and my concept
AAD | Best Practices for Prior Authorization
Top strategies for prior authorization ... 1. The process of prior authorizations can be painful. Accept that it will take time. ... 2. Assign a dedicated staff member (such as a medical assistant) to handle prior authorization requests, so as a dermatologist, you have more time with patients and more
Senile gluteal dermatosis: The term “senile” is getting old and should be retired
By Warren R. Heymann, MD, FAAD Jan. 24, 2024 Vol. 6, No. 4 As my patients and I get older, inevitably I think more about geriatric dermatology. (1) There is a disorder I have seen on the gluteal region in mostly thin, older, sedentary patients — my recommendations of off-loading
March 25, 2020
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / March 25, 2020 ... C MS extends 2019 MIPS reporting deadline DW Insights and Inquiries : The profound dermatological manifestations of COVID-19 – Part 2 Young Physician Focus : A legitimate
Paradoxical biological reactions and Grandma Dora’s waterbed
By Warren R. Heymann, MD January 22, 2020 Vol. 2, No. 3 My late maternal grandmother Dora — a real ... balabusta (Yiddish for "mistress of the house") — was the first person I knew to get a waterbed. That raised eyebrows, until I explained that it comforted her octogenarian
Basic Dermatology Curriculum
The American Academy of Dermatology has a long history of involvement in medical student education. This curriculum was created by a work group of experienced dermatology educators and is based on the best available evidence. ... Note ... If this is the first time you are accessing the Academy's online
The profound dermatological manifestations of COVID-19: Part IV – Cutaneous features
By Warren R. Heymann, MD April 22, 2020 Vol. 2, No. 16 Disclaimers: This commentary was written on April 17, 2020 for a publication date of April 22, 2020. The issues related to the COVID-19 pandemic are changing by the millisecond. The content included in this commentary may no longer
Vulvar hidradenoma papilliferum and mammary-like gnogenital glands: The whole story
By Warren R. Heymann, MD July 31, 2016 I had always assumed that hidradenoma papilliferum (HP), which characteristically appears in the vulvar region, was derived from apocrine glands. Until I read the article by El-Khoury et al (1) I had never even heard of mammary-like anogenital glands (MLAGs). ... Although
A niche within NICH
By Warren R. Heymann, MD February 26, 2020 Vol. 2, No. 8 Just when I thought I grasped the concept of congenital hemangiomas, new data raises novel questions. ... Compared to infantile hemangiomas that grow rapidly after birth and then involute, congenital hemangiomas arise and proliferate in utero. Although two
Recognizing Trichophyton indotineae
Reporting to health departments ... Physicians who suspect antimicrobial-resistant dermatophytosis can also contact ... their state or local health departments for assistance . Public health officials who are concerned about potential cases or clusters of drug-resistant tinea infections can email ... fungaloutbreaks@cdc.gov for assistance with recommendations and testing. ... Overview
December
Issue ... December January February March April May June July August September October November December View digital flipbook In this issue ... From the Editor ... From the editor Asked and Answered ... How can I use DataDerm to report for MIPS? What's hot ... What's hot? Cracking the Code
June 30, 2021
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / June 30, 2021 ... Treating atopic dermatitis with cognitive behavioral therapy: Does it work? DermWorld Insights and Inquiries : Deep learning in dermatopathology Sublingual tofacitinib for alopecia areata Biologic psoriasis treatments
The 21st Century Cures Act: What a difference a day makes
By Warren R. Heymann, MD, FAAD Sept. 24, 2025 Vol. 7, No. 38 The 21st Century Cures Act (Cures Act, CA) was signed into law on Dec. 13, 2016. (1) In April 2021, the Information Blocking Rule (IBR) of the CA went into effect, giving patients immediate access to notes,
Prurigo pigmentosa as the “keto rash”: I’m a believer
By Warren R. Heymann, MD February 5, 2020 Vol. 2, No. 5 Patients are attuned to their diets — healthy, unhealthy, or trendy. Unquestionably, certain foods exacerbate specific dermatoses — just ask any dermatitis herpetiformis patient how they fare with a slice of Sicilian pizza. More often the situation is
On the cusp of extraordinary advances in extramammary Paget disease
By Warren R. Heymann, MD May 27, 2020 Vol. 2, No. 21 I always include extramammary Paget disease (EMPD) and Bowen disease in my differential diagnosis of anogenital rashes for fear of missing them. It is good form to biopsy such lesions should they not respond to standard therapies for
New data to recall when considering radiation recall dermatitis
By Warren R. Heymann, MD Sept. 30, 2020 Vol. 2, No. 39 I have always been mystified by the diagnosis of radiation recall dermatitis (RRD). RRD was first described in 1959 by D’Angio et al who stated: "Actinomycin D therapy alone can reactivate ‘latent’ radiation effects in normal tissues. For
January
Issue ... January January February March April May June July August September October November December View digital flipbook In this issue ... From the Editor ... From the editor What's hot ... What's hot? Cracking the Code ... CPT 2018: What's new, part 2 Acta Eruditorum ... Can chimeric antigen
CMS creates permanent drug code for treating molluscum contagiosum
CMS has created a permanent drug code, J7354, for cantharidin, a drug used to treat molluscum contagiosum in adult and pediatric patients 2 years and older. The new J-code became effective on April 1, 2024. ... Cantharidin is the first ... FDA-approved topical treatment for molluscum contagiosum. The manufacturer provides
Best of DermWorld Insights and Inquiries
Dec. 27, 2023 We know how much you enjoy Dr. Heymann and the editorial board’s weekly analyses of dermatologic literature, so we’ve created a list of the top 10 most popular issues in 2023 — starting with the most popular issue of the year. ... 1. After 23 years, a
Volunteer duty, chapter 2
From the President ... Dr. Tomecki served as Academy president from March 2021 to March 2022. ... By Kenneth Tomecki, MD, June 1, 2021 Volunteer, n...person who performs/gives his/her services of own free will; v...to give/offer to give on one’s own initiative. I highlighted the main AAD volunteering opportunities in
Taking biologics to heart
By Warren R. Heymann, MD Oct. 16, 2016 Comorbidities related to psoriasis have dominated the dermatologic literature for more than a decade since Joel Gelfand published his seminal paper (1). In my 2008 commentary for ... Dialogues in Dermatology , I stated that "It remains to be determined if treating
What's hot?
What's hot ... January 2, 2019 In this monthly column, members of the ... Dermatology World Editorial Advisory Workgroup identify exciting news from across the specialty. ... Mallory Abate, MD ... Many dermatologists still check baseline labs prior to prescribing oral terbinafine or griseofulvin for adults and children with dermatophyte
November
Issue ... November January February March April May June July August September October November December View digital flipbook In this issue ... From the Editor ... So, what's a Kodachrome? What's hot ... This month's news from across the specialty Clinical Applications ... When is pyoderma gangrenosum not pyoderma gangrenosum?
We’re in hot water! Vibrio vulnificus infections are heading north
By Warren R. Heymann, MD Dec. 16, 2020 Vol. 2, No. 49 When driving to work, I usually listen to our local 24-hour news station, paying half-attention as I’m mentally sorting out the upcoming day’s agenda. Upon hearing a report of several cases ... Vibrio vulnificus (Vv) at my hospital
The 2020 vision for nemolizumab in atopic dermatitis
By Warren R. Heymann, MD March 11, 2020 Vol. 2, No. 10 Over the past decade, I have noticed an inversion of the ratio of patients with severe psoriasis versus atopic dermatitis (AD) in my practice. The biologic revolution has clearly favored those afflicted with psoriasis; although dupilumab has improved
Acquisition and loss: A tribute to Jouni Uitto, MD, PhD
By Warren R. Heymann, MD, FAAD Jan. 11, 2023 Vol. 5, No. 2 I was stunned and frozen in time and thought when Dr. Sylvia Hsu informed me that Dr. Jouni Uitto had passed away — a similar reaction as I experienced when hearing of President Kennedy’s or John Lennon’s
Teledermatology workflow for small practices
Use the workflow below to help you implement or improve your teledermatology operations. This version is designed for solo or small practices. There is a distinct PDF guide for dermatologists who practice in an ... academic or multispecialty organization . ... 1. Technology setup ... Create a generic account on
Topical amelioration of neuropathic pain and pruritus leading to painful consequences
By Warren R. Heymann, MD Dec. 26, 2016 Increasingly, compounded amitriptyline and ketamine have been utilized for the management of neuropathic pain and pruritus. A review of PubMed reveals its utility in erythomelalgia and diverse neuropathic disorders (peripheral neuropathy, radiation-induced neuropathy, chemotherapy-induced neuropathy, post-herpetic neuralgia, proctodynia, and pain associated with
Top drivers of dermatologist happiness
Facts at your Fingertips ... By Emily Margosian, assistant editor, September 2, 2019 What do a solo practitioner and employee at a large health system have in common? The same things make them pretty happy. According to data from the AAD’s 2019 Life in Practice Study, dermatologists across all practice
Skin in the news
Facts at your Fingertips ... By Emily Margosian, content specialist, April 2, 2018 In 2017, the Academy generated more than 8.8 billion media impressions in print and online — akin to reaching each person in the United States more than 26 times. Nevertheless, the year’s overall total marked a slight
Can topical ketoconazole tip the scales for acne vulgaris?
By Warren R. Heymann, MD Oct. 28, 2020 Vol. 2, No. 43 How often do you perform an oral examination? If you’re like me, probably only under two circumstances — when the patient has specific complaints (soreness, a raised lesion, or a discoloration noted by their dentist), or when we
Topical tacrolimus topics
By Warren R. Heymann, MD August 26, 2020 Vol. 2, No. 34 What were you doing in 2000? Worrying about counting chads in Florida? If you were a dermatologist, you were probably eagerly awaiting the release of topical tacrolimus (Protopic) and pimecrolimus (Elidel) two years later. These topical calcineurin inhibitors
Having a mentor helped Kala S. Hurst, DO, become a dermatology resident.
Having a mentor helped Kala S. Hurst, DO, become a dermatology resident. Dr. Hurst's story ... Kala Hurst, DO, University Hospitals/Case Western Reserve University’s Department of Dermatology, PGY-2. ... I applied to the AAD Diversity Mentorship Program, but actually did not receive the award. Instead, I found my mentor, AAD
Our public-facing AAD.org content performs strongly
One of the many benefits of the Your Dermatologist Knows consumer positioning strategy is driving traffic to the public-facing pages of the AAD.org website. During the first five months of 2023, over ... 20 million visitors viewed webpages over ... 28 million times. In the same timeframe, the Academy updated
Skin cancer incidence and related deaths projected to rise in 2024
Facts at your Fingertips ... By Emily Margosian, Assistant Editor, April 1, 2024 The latest data from the American Cancer Society (ACS) are in — offering new insights into the impact of skin cancer on public health in the United States. Each year, the ACS estimates the number of new
New Medicare cards
In Practice ... Rachna Chaudhari is the AAD's practice management manager. Her column offers tips in response to common member questions. ... By Rachna Chaudhari, MPH, director of practice management, April 2, 2018 ... The Centers for Medicare and Medicaid Services (CMS) recently announced that it would be changing your
2021: Best of DermWorld Insights and Inquiries
December 30, 2021 We know how much you enjoy Dr. Heymann and the editorial board’s weekly analyses of dermatologic literature, so we’ve created a list of the top 10 most popular issues in 2021 — starting with the most popular issue of the year. ... 1. Biotin supplementation for hair
Life insurance 101: Options and considerations
Money Matters ... David B. Snyder, JD, CLU ... ® ... , is an attorney, author, and financial advisor at the wealth management firm OJM Group. He covers financial issues for dermatologists in this quarterly ... Dermatology World column. ... By David B. Snyder, JD, CLU, September 2, 2019 Life
Dermatologists should not be in the dark about kratom
By Warren R. Heymann, MD, FAAD Oct. 11, 2023 Vol. 5, No. 41 Dermatological sleuthing mandates an ever-expanding knowledge database. The correct diagnosis may prove elusive if you do not know the right questions to ask. Astute clinicians have a differential diagnosis of cutaneous and/or mucosal hyperpigmentation, including heavy metal
How can I get involved with this year’s Legislative Conference?
Asked and Answered ... July 1, 2024 The 2024 AADA Legislative Conference will take place Sept. 8-10, at the JW Marriot in Washington, D.C. ... Attending the conference is as easy as 1, 2, 3. You can expect: ... Two days of networking and learning from political experts about the
Recognizing mpox
The information on this page was created by the Academy’s Ad Hoc Task Force to Develop Mpox Content. Mpox (monkeypox) is caused by the mpox virus, which belongs to the ... Orthopoxvirus genus in the family Poxviridae. ... 1 ... Though mpox is rare, it is endemic in Central and West
New American Academy of Dermatology survey shows most Americans are not concerned about skin cancer, even if they are at risk
Board-certified dermatologists urge the public to practice safe sun ROSEMONT, Ill. (April 25, 2023) — As an African American female, Ilia Smith didn’t think she would get melanoma. However, after years of tanning and being outdoors, her life changed drastically when she was diagnosed with stage 2 melanoma. While Ilia
Skin cancer incidence and related deaths projected to increase in 2025
Facts at your Fingertips ... By Emily Margosian, Assistant Editor, May 1, 2025 The latest data from the American Cancer Society (ACS) are in — offering new insights into the impact of skin cancer on public health in the United States. Each year, the ACS estimates the number of new
Twenty years of imiquimod taking its toll on lentigo maligna — Where are we?
By Warren R. Heymann, MD February 12, 2020 Vol. 2, No. 6 Although Y2K never amounted to much, a solitary case report that year changed the dynamic in treating a vexing problem — melanoma in situ of the lentigo maligna (LM) subtype. Ahmed and Berth Jones reported treating an 88-year
Streamlining the claim denial process in your practice
Claim denials are a reality for every dermatology practice. It is wise to be proactive and understand what you need to do when you receive a claim denial. Streamlining your claim denial process requires understanding the meaning behind each denial on the explanation of benefits (EOB) and the appropriate action
Move over Lues: Graft-versus-host disease is the new mimicker king
By Warren R. Heymann, MD May 9, 2016 I have always been intrigued by graft-versus-host disease (GVH). I first learned of the disorder in my college immunology course when it was referred to as a cause of "runting syndrome" in mice. ... In the context of transplant recipients, classical features
2020 Academy Meeting cancellation and refund support
View your existing registration & housing record ... The 2020 Academy Meeting has been canceled due to the COVID-19 outbreak. Click on the button below to access your existing registration and housing record. ... Registration refunds ... The AAD will automatically cancel your existing registration and refund all fees, including
How can I get involved with this year’s Legislative Conference?
Asked and Answered ... July 1, 2023 The 2023 AADA Legislative Conference will take place Sept. 10-12, at the Conrad Hotel, in Washington, D.C. ... Attending the conference is as easy as 1, 2, 3. You can expect: ... Two days of networking and learning from political experts about the
Should systemic steroids be avoided in atopic dermatitis?
Acta Eruditorum ... Dr. Schwarzenberger is the former physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, July 2, 2018 In this month's Acta Eruditorum column, Physician Editor Kathryn Schwarzenberger, MD, talks with Jonathan I. Silverberg, MD, PhD,
Slammed by slime
By Warren R. Heymann, MD Sept. 16, 2020 Vol. 2, No. 37 Visiting Nickelodeon Studios in Orlando, Florida in the early 1990s was a religious experience for my family. Watching a live recording of ... Double Dare, my daughters were fervently praying to be among the chosen few to be
Skin cancer snapshot: National rates fall, men remain vulnerable
Facts at your fingertips ... By Emily Margosian, assistant editor, May 1, 2020 The results of the American Cancer Society’s (ACS) 2020 projections are in. Each year, the ACS estimates the number of new cancer cases and deaths in the United States by compiling the most recent data on population-based
Striving for hard facts about water softening in atopic dermatitis
By Warren R. Heymann, MD, FAAD Aug. 18, 2021 Vol. 3, No. 33 With the success of dupilumab in managing atopic dermatitis (AD), and new agents on the horizon (IL-13 inhibitors lebrikizumab and tralokinumab; the IL-31 inhibitor nemolizumab; targeted anti IL-17, IL-22, and TSLP inhibitors; JAK inhibitors; and the PDE4
Mentorship mentation: Bringing out the best of us!
By David A. Wetter, MD Sept. 9, 2020 Vol. 2, No. 36 I have been experiencing sports withdrawal during this COVID-19 life pause. I even (excitedly) gobbled up the recently televised NBA HORSE competition. Currently my family and I are enjoying ESPN’s 10-hour documentary ... The Last Dance , which
Necrobiosis lipoidica in a Wink
By Warren R. Heymann, MD, FAAD May 3, 2023 Vol. 5, No. 18 Ninety years have transpired since Urbach coined the term ... necrobiosis lipoidica diabeticorum (NLD) for the granulomatous disorder first described by Oppenheim in 1929 as ... dermatitis atrophicans lipoidica diabetica . (1) Early authors observed sclerotic plaques
Vasculitis on the run
By Warren R. Heymann, MD, FAAD July 10, 2024 Vol. 6, No. 28 I am not a runner, but I live vicariously through my residents who are. This weekend, our first-year resident, Erika Tvedten, will run the Philadelphia marathon for the first time. I have been intrigued (and impressed!) by
Patient preference in dermatologist attire: A lesson from “Annie”
By Warren R. Heymann, MD June 5, 2016 The physician-patient relationship is predicated on trust and confidence. Impressions form rapidly and physician attire is an important component on how patients perceive their physician(s). ... Fox et al surveyed 255 patients (with 63% from a medical dermatology clinic, 24% a dermatologic
Dermatology and dermatopathology awake: now is the time to embrace the artificial intelligence revolution
By Jason B. Lee, MD June 23, 2021 Vol. 3, No. 25 In 1991, the late Dr. A. Bernard Ackerman sounded the alarm about the decline in the interest in dermatopathology by dermatologists in an effort to preserve this foundational subspecialty within dermatology. (1) Although not with the same urgency,
PDF of industry expert sessions for theater 2
INDUSTRY EXPERT SESSIONS Friday, March 20, 2020 Theater 2 These unique sessions provide
Glucose monitors: Not as sweet as they seem
By Christen M. Mowad, MD Oct. 9, 2019 Vol. 1, No. 31 ... The next contact allergen of the year has been announced early by the American Contact Dermatitis Society and it is an acrylate, isobornyl acrylate. (1) This chemical is a photopolymerizable monomer that has been used in industrial
Another mastocytosis surprise: IgM on DIF in bullous mastocytosis
By Warren R. Heymann, MD ... May 2, 2016 ... If I read my horoscope this week, it would no doubt say "Beware of any preconceived notions in your patients with mastocytosis." ... Now that I have expanded my horizons about TMEP, I also need to reconsider the notion that
AAD letter to the Wall Street Journal in response to “$500,000 Pay, Predictable Hours: How Dermatology Became the ‘It’ Job in Medicine”
American Academy of Dermatology President Seemal R. Desai, MD, FAAD Letter to the editor originally submitted to the Wall Street Journal ... on Nov. 20, 2024 ROSEMONT, Ill. (Dec. 2, 2024) — On behalf of the American Academy of Dermatology and its 21,000 members, I am writing to express very serious concerns
American Academy of Dermatology warns that homemade sunscreens are not proven to be effective and may leave users vulnerable to skin cancer
American Academy of Dermatology Secretary-Treasurer Daniel D. Bennett, MD, FAAD ROSEMONT, Ill. (July 2, 2024) — While the American Academy of Dermatology is aware of reports of people using homemade sunscreens, research shows that most homemade sunscreens lack effective sun protection, leaving users vulnerable to sunburn, premature skin aging and
JAAD ranks no. 1 among dermatology journals
The Journal of the American Academy of Dermatology’s impact factor remains #1 in field ROSEMONT, Ill. (July 2, 2024) — The ... Journal of the American Academy of Dermatology remains the top peer-reviewed journal in its field, according to the 2023 journal impact factor rankings recently published by Clarivate’s Journal
Changing a long-standing habit
By Warren R. Heymann, MD April 16, 2016 Topical corticosteroid has no influence has no influence on inflammation or efficacy after ingenol mebutate treatment of grade I to III actinic keratosis (AK): A randomized clinical trial. ... This is a randomized controlled clinical trial of patients with multiple AK and
The H syndrome – Understanding Y
By Warren R. Heymann, MD April 15, 2020 Vol. 2, No. 15 It has been more than a decade since the H syndrome was described by Molho-Pessach et al, in their report of 10 patients from 6 Arab consanguineous families. (1) More than 100 cases have now been reported worldwide.
Anterolateral leg alopecia: An example of a new dermatologic statistic — seen but unrecognized
By Warren R. Heymann, MD March 4, 2020 Vol. 2, No. 9 Aside from my family, my two greatest passions in life are dermatology and baseball. There is an infinite amount to learn in each discipline — for wisdom in each I turn to Bill James (two different people). Most
PDF of measure AAD 2 flowchart
DIRECT EHR AAD #2: Psoriasis: Screening for Psoriatic Arthritis — National Quality Strategy Domain:
Providing consistent quality care requires due diligence.
From the President ... Dr. Olbricht served as Academy president from March 2018 to March 2019. ... By Suzanne Olbricht, MD, July 2, 2018 Sometimes the news makes me cringe, especially reports about a physician or their non-physician providers making questionable treatment decisions. Even though the stories are usually about
Frontal fibrosing alopecia: Bewitched, bothered, and bewildered
By Warren R. Heymann, MD Feb. 13, 2017 Women given the diagnosis of frontal fibrosing alopecia (FFA) with different severity grades. A, FFA grade I/V in a premenopausal 30-year-old woman, with a less than 1-cm wide area of cicatricial skin produced by the recession of the frontal and temporal hairline.
Knuckling down on knuckle pads
By Warren R. Heymann, MD April 1, 2020 Vol. 2, No. 13 Today is April Fools’ Day. Thus far, 2020 has felt like April Fools’ Year. All of us are dealing with COVID-19, 24/7. During World War II, morale was lifted by the song "There’ll be bluebirds over the White
Coding and documentation clarity
Cracking the Code ... Dr. Miller, who is in private practice in Yorba Linda, California, represents the American Academy of Dermatology on the AMA-CPT Advisory Committee. ... By Alexander Miller, MD, April 2, 2018 You biopsy a suspected drug eruption and document the following: "Punch biopsy done. Return in 1
Obituaries
Obituaries ... By Jerry Graff, MD, September 2, 2019 The Academy recently learned with sorrow of the passing of the following members of the dermatologic community. ... JOHN L. AELING, MD, of Orlando, Florida, Oct. 26, 2018, at age 82. Trained at National Capital Area Consortium Dermatology Residency Program. ...
Recognizing toxic epidermal necrolysis-like acute cutaneous lupus erythematosus ASAP
By Warren R. Heymann, MD, FAAD November 10, 2021 Vol. 3, No. 45 ASAP, the well-recognized acronym for "as soon as possible," takes on special significance for dermatologists confirming the diagnosis of toxic epidermal necrolysis (TEN). In 2004, Ting et al introduced an alternative definition of the ASAP acronym —
Preferentially expressed antigen in melanoma (PRAME)
By Jason B. Lee, MD, FAAD May 10, 2023 Vol. 5, No. 19 In 1980, the discovery of S100 protein expression in cultured metastatic melanoma cell lines (1) stirred excitement in the pathology community for its potential role as a diagnostic marker for melanoma. The excitement was short-lived once it
Getting steamed over vaping
By Danielle DeHoratius, MD January 29, 2020 Vol. 2, No. 4 Danielle DeHoratius, MD ... To call vaping an epidemic is an understatement. As of Oct. 15, 2019, the CDC has confirmed 33 deaths among the 1,479 lung injuries associated with the use of e-cigarettes (1). Every state but Alaska
Focus on modifier 25
Cracking the Code ... Dr. Miller, who is in private practice in Yorba Linda, California, represents the American Academy of Dermatology on the AMA-CPT Advisory Committee. ... By Alexander Miller, MD, September 2, 2019 Test your knowledge: Focus on modifier 25 ... Take the quiz to see if you're up
Metformin mania: Is it an adequate chemopreventive agent for skin cancer?
By Warren R. Heymann, MD, FAAD Aug. 31, 2022 Vol. 4, No. 35 Precisely a century ago (in 1922) metformin was synthesized, based on the folk knowledge that the active, but toxic constituent guanidine galegine, (derived from French lilac, ... Galega officinalis ) could treat "sweet urine." Metformin is now
Treatments for renal IgA vasculitis are beginning to flow
By Warren R. Heymann, MD, FAAD Feb. 19, 2025 Vol. 7, No. 7 The alliterative phrase "palpable purpura" will instantly conjure the diagnosis of leukocytoclastic vasculitis (LCV) for dermatologists. IgA vasculitis (IgAV, aka Henoch-Schönlein purpura [HSP]) is the most common vasculitis in children but is much less frequent in adults.
DWI&I Holiday Greeting 2020
By Warren R. Heymann, MD Dec. 23, 2020 Vol. 2, No. 50 Dear ... DWI&I Devotee: ... For my 65th birthday this year, my wonderful older brother George presented me with a marvelous gift — a leather-bound compilation of the front page of ... The New York Times including every
How to maintain your EHR
Dealing with your EHR can be cumbersome, but follow these tips to optimize your EHR and make your use more efficient. ... 1. Connect leadership and EHR users ... Boosts provider satisfaction long-term and reduces slowdown. ... 2. Enhance hardware and built-environment solutions ... Implement side-by-side seating for physicians, clinical
Granulomatous slack skin: More than one type of mimicry
By Warren R. Heymann, MD November 18, 2020 Vol. 2, No. 46 My chief resident presented a case to me enamored with his clinical diagnosis of granulomatous slack skin (GSS). Although I was delighted that he considered the disorder, I explained why I thought these inguinal and submammary pink-white subtly
Much ado about nothing in dermatopathology
By Warren R. Heymann, MD Dec. 9, 2020 Vol. 2, No. 48 In a utopian dermatology practice, an astute dermatologist will establish an exacting differential diagnosis, biopsy the most revealing lesion utilizing a technique providing an optimal sample, label the bottle correctly, fill out a requisition form with care and
The profound dermatological manifestations of COVID-19: Part VII — Who was that masked man?
By Warren R. Heymann, MD Sept. 23, 2020 Vol. 2, No. 38 Disclaimers: This commentary was written on Sept. 12, 2020 for a publication date of Sept. 23, 2020. The issues related to the COVID-19 pandemic are changing rapidly. The content included in this commentary may no longer be factual
Targeted anti-complement therapy may prove to be a complementary treatment for bullous pemphigoid
By Warren R. Heymann, MD Oct. 7, 2020 Vol. 2, No. 40 It is not my imagination — I have been seeing more cases of bullous pemphigoid (BP) than ever. This is likely a function of an aging population in concert with an increase of drug-induced cases, notably with dipeptidyl
New evaluation and management (E/M) coding changes are coming in 2021 – Practical applications of the 2021 E/M coding changes
Selecting the E/M level of service ... Part 3 of the "E/M coding changes are coming in 2021" series will focus on the practical application of the changes to dermatology-specific encounters based on ... medical decision making (MDM) or ... time . (Review ... part 1 and ... part 2
How should dermatologists manage contact allergies to botanicals?
Clinical Applications ... Dr. Schwarzenberger is the former physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, FAAD, June 1, 2024 In this month’s Clinical Applications column, DermWorld ... Physician Editor Kathryn Schwarzenberger, MD, FAAD, talks with Mark
The profound dermatological manifestations of COVID-19: Part III
By Warren R. Heymann, MD April 8, 2020 Vol. 2, No. 14 Disclaimers: This commentary was written on April 5, 2020 for a publication date of April 8, 2020. The issues related to the COVID-19 pandemic are changing by the millisecond. The content included in this commentary may no longer
Coronavirus – Frequently Asked Media Questions
Talking points for members ... 1. How do you keep your hands from getting dry, given how often you have to wash them? What hand lotion do you use? After washing your hands, apply a petrolatum/mineral oil-based cream that is fragrance and dye free. Ointments and creams — the ones
Best of DermWorld Insights and Inquiries
Dec. 26, 2024 We know how much you enjoy Dr. Heymann and the editorial board’s weekly analyses of dermatologic literature, so we’ve created a list of the top 10 most popular issues in 2024 — starting with the most popular issue of the year. ... 1. Weighing in on glucagon-like
Cannabis arteritis: Getting higher on the differential diagnosis list of ulcerative lesions
DermWorld Insights and Inquiries ... By Warren R. Heymann, MD, FAAD, January 1, 2026 Vol. 8, No. 1 Marijuana use is on the rise. In 2022, nearly 22% of people had used the drug in the past year, with steep increases in the number of people 65 and older who
Et tu, Ibrutinib?
By Warren R. Heymann, MD July 8, 2020 Vol. 2, No. 27 When it comes to medications that I never prescribe, I learn from my patients who present with findings that compel me to do my homework. Such was the case of a middle-aged woman with chronic lymphocytic leukemia (CLL)
Nailing the diagnosis of the BAP1 tumor predisposition syndrome
By Warren R. Heymann, MD, FAAD June 5, 2024 Vol. 6, No. 23 I never imagined that I would be writing another commentary on onychopapillomas (Ops) so soon. The initial commentary was devoted to rare malignant Ops. (1) Unsurprisingly, additional reports of malignant Ops have been reported. (2) What else
From the editor
From the Editor ... Dr. Schwarzenberger is the former physician editor of ... DermWorld. By Kathryn Schwarzenberger, MD, July 2, 2018 I love a good disaster movie. Epic, poorly overacted tales of impossibly large hurricanes, tsunamis, tornados (even sharknados), and cataclysmic blizzards amuse me like no other movie genre. Like
PDF of Drug interactions in dermatology, part 2
American Academy of Dermatology | Association boards fodder Drug Interactions in Dermatology, Part 2
What does it mean when all of a patient's patch tests come back negative?
Clinical Applications ... Dr. Schwarzenberger is the former physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, September 2, 2019 In this month’s Clinical Applications column, Physician Editor Kathryn Schwarzenberger, MD, talks with Erin Warshaw, MD, MS, about
AccessDerm: Serving the underserved
In Practice ... Dr. Simpson serves in the Department of Dermatology at University of Pennsylvania. ... By Dean Monti, managing editor, special publications, September 2, 2019 Dermatology World speaks with Cory Simpson, MD, PhD, about why he uses AccessDerm — the Academy's volunteer teledermatology platform — how it works, and
The times they are a-changin'
From the President ... Dr. Hruza served as Academy president from March 2019 to March 2020. ... By George Hruza, MD, MBA, September 2, 2019 Who knew more than 50 years ago, that this iconic Bob Dylan song could apply to health care? The U.S. health care system has weathered
The evolution of practice settings
From the President ... Dr. Olbricht served as Academy president from March 2018 to March 2019. ... By Suzanne Olbricht, MD, April 2, 2018 In my ... introductory column as your Academy President, I addressed the many changes facing dermatology and medicine. Over time we have found ourselves adapting to
2021 is finally here
From the Editor ... Dr. Schwarzenberger is the former physician editor of ... DermWorld. By Kathryn Schwarzenberger, MD, January 1, 2021 While 2020 started off innocently enough, the cancellation of the Annual Meeting, shocking as it seemed at the time, was perhaps the first hint that this was not to
Incysting on understanding pilar cysts
By Warren R. Heymann, MD July 15, 2020 Vol. 2, No. 28 Chances are you will see patients with at least one pilar cyst today. You will reassure them of their benignity, stating that the risk of their becoming cancerous is infinitesimal, and perhaps you will excise some lesions. Inquisitive
Shining a light on the Sunshine Act
Legally Speaking ... Daniel F. Shay, Esq. is a health care attorney at Alice G. Gosfield and Associates, P.C. ... By Daniel F. Shay, Esq., July 2, 2018 The "Sunshine Act" as it has come to be known (stemming from Sen. Charles Grassley’s position that sunshine is the best disinfectant)
From the editor
From the Editor ... Dr. Schwarzenberger is the former physician editor of ... DermWorld. By Kathryn Schwarzenberger, MD, Physician Editor, September 2, 2019 Last month, we introduced you to digital marketing. Many of our younger members already use their websites and social media platforms to successfully manage and highlight their
AAD Teledermatology Standards
Download a PDF version ... These ... AAD Teledermatology Standards are also available as a PDF. ... The standards below were developed by the Academy’s Teledermatology Committee at the direction of the Board of Directors. These standards expand upon the appropriate use of telemedicine and create a core set of
What to expect for MIPS 2024
Answers in Practice ... By Olivia Barry, Manager, Practice Management, April 1, 2024 Each month, DermWorld ... tackles issues "in practice" for dermatologists. This month, practice management staff explains what to expect for MIPS 2024. On Nov. 2, 2023, CMS released the final Quality Payment Program (QPP) Rule which includes
This month’s news from across the specialty
What’s hot ... December 1, 2023 In this monthly column, members of the ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty. ... Bryan Carroll, MD, PhD, FAAD Our surgical prep may benefit non-surgical elderly patients. A study of extended bacterial decolonization in 28,956 nursing home
PDF of PI #2, closing referral loops
of the patient's medication, including the name, dosage, frequency, and route of each medication; (2)
From the editor
From the Editor ... Dr. Schwarzenberger is the former physician editor of ... DermWorld. By Kathryn Schwarzenberger, MD, April 2, 2018 I hope you enjoyed the AAD Annual Meeting in San Diego. I certainly did. I came home yet again feeling renewed, returning to the clinic armed with new knowledge
For patients with erythropoietic protoporphyria the tide has come in
By Warren Heymann, MD May 12, 2021 Vol. 3, No. 19 Oct. 8, 2019, was an eventful day for patients with erythopoietic protoporphyria (EPP) in the United States, when the FDA announced its approval of afamelanotide (Scenesse). (1) The drug was first approved in Italy in 2010. (2) ... Patients
Diabetes and your skin
Dermatologist explains how diabetes affects the skin and the importance of proper skin care ROSEMONT, Ill. (November 2, 2022) — Your skin is a window to your overall health, and what happens on your skin is often an indicator of what’s happening inside your body. Skin, hair, and nail conditions
Melanoma controversies
Screening, biopsy practices questioned as incidence rate increases ... Feature ... By Jan Bowers, contributing writer, September 1, 2021 At first glance, dermatologists would seem to be wildly successful in their decades-long effort to detect and remove cutaneous melanoma lesions before they can metastasize and become deadly. According to the
Directions in Residency archive
Download PDF versions of each issue ... Winter (PDF) ... Feature: Financial planning in residency: Frequently asked questions — Part 1 by David B. Mandell, JD, MBA ... Race for the Case: Winter 2025 by Haowei Han, DO, and Aysham Chaudry, DO ... Boards Fodder: Promontory sign microscopic differential diagnosis
Is your dermatology practice's website ADA compliant?
Legally Speaking ... Robert M. Portman, JD, MPP, is a health care attorney with Powers Pyles Sutter & Verville, in Washington, DC, and serves as legal counsel for the AAD and AADA. ... By Christina L. Krysinski, JD, and Robert M. Portman, JD, September 2, 2019 The Americans with Disabilities
Trialing it out
In Practice ... Craig Leonardi, MD, from Central Dermatology in St. Louis, specializes in treatment of moderate to severe psoriasis and other dermatologic diseases. He is also an adjunct professor of dermatology at St. Louis University Medical School. ... By Victoria Houghton, assistant managing editor, July 2, 2018 Dermatology World
What are the CLIA requirements for lab operations?
Thanks to persistent ... advocacy by the AADA , CMS has suspended enforcement of a controversial CLIA policy that would have excluded board-certified dermatologists from serving as lab directors for moderate- and high-complexity labs. Under this suspension, CMS: ... Allows individuals qualified as technical supervisors to qualify as laboratory directors
Advocacy Update Dec 9, 2025
IN THIS ISSUE / Dec. 9, 2025 AADA endorses annual inflationary update to Medicare payment legislation Upcoming formulary prior authorization changes to Blue Cross Blue Shield’s federal employee coverage Podcast highlights advocacy on dermatopathology payer and regulatory challenges AMA offering $1 million in community health program grants Peter Friedman, MD,
Smoke and the skin
Experts discuss the cutaneous impact of occupational and natural exposure to smoke. ... Feature ... By Emily Margosian, Senior Editor, June 1, 2025 From wildfires to cigarettes, smoke drifts through every corner of life. ... Nearly 90% of the world’s population lives with unhealthy air caused by smoke, according to
2024 AAD Annual Meeting Sponsorship Prospectus
event signage throughout the reception and name recognition in event remarks, plus an invitation for 2-
2024 MIPS update
What dermatologists need to know about this year’s MIPS reporting. ... Feature ... By Allison Evans, Assistant Managing Editor, May 1, 2024 "If you provide Medicare services, MIPS is a must when it comes to your reimbursement," said Florida dermatologist Shawna Flanagan, MD, FAAD, member of the Academy’s Practice Management
Our donors
We welcome this year's generous donors into the following giving societies and thank them for their commitment to advancing the programs and services of the Academy, especially those who have given consecutively for the past 5+ years. ... 1938 Legacy Society (Transformational gift) ... Bruce D. Glassman, MD, FAAD ...
Advocacy Update Feb. 18 2025
IN THIS ISSUE / Feb. 18, 2025 AADA, house of medicine demand reversal of Medicare cut and provide a pay boost AADA highlights need for Medicare physician payment reform at House Committee on Ways and Means hearing Dermatology addresses new CLIA requirements for lab directors Legislators reject pharmacists’ effort to
Advocacy Update Mar. 18, 2025
IN THIS ISSUE / Mar. 18, 2025 AADA outraged that Congress passed government funding without doc fix AADA advocates for dermatologists in CLIA lab director requirements FDA testing confirms minimal benzene in most benzoyl peroxide acne products, some voluntary recalls issued Add your voice and become an AADA Advocacy Key
PDF of Soft tissue fillers, non-biodegradable pt 2
Academy of Dermatology | Association directions in residency boards fodder Soft tissue fillers, part 2:
Leaders in medicine – Part 2
DermWorld talks to dermatologists in leadership roles in the house of medicine. ... Feature ... By Matthew Walsh, Member Communications Specialist, June 1, 2023 This is the second part of a series of interviews in which ... DermWorld spoke with nine board-certified dermatologists who serve or have served in important
Biotin supplementation for hair and nail health: Does it pass the test?
By Warren R. Heymann, MD, FAAD November 17, 2021 Vol. 3, No. 46 When patients ask me about biotin supplementation for their hair or nails, the usual question is what dose they should take, not whether or not it has any value. High dose over-the-counter biotin supplements (≥ 5 mg/day,
One size does not fit all
Dermatologists discuss considerations and complexities in caring for older adults with skin cancer. ... Feature ... By Allison Evans, Assistant Managing Editor, February 1, 2024 In the same way that children cannot be treated as little adults, older adults (65+ years old) cannot be treated the same as younger adults.
Key messages to communicate about Indoor tanning
Key messages ... Using indoor tanning beds can increase your risk of skin cancer, including melanoma, the deadliest form of skin cancer. (1-15) ... Using tanning beds before age 20 can increase your chances of developing melanoma by 47%, and the risk increases with each use. (16) ... Women younger
PDF of Article III Section 2 Eligibility rights and obligations
BYLAWS ARTICLE III Membership Section 2.
COVID-19 impact on employed dermatologists: Part 2
Legally Speaking ... Robert M. Portman, JD, MPP, is a health care attorney with Powers Pyles Sutter & Verville, in Washington, DC, and serves as legal counsel for the AAD and AADA. ... By Ben Tesdahl, JD, Megan La Suer, JD, MHA, and Rob Portman, JD, MPP, October 1, 2020
March 20, 2023 AAD/A Board of Directors agenda
Request to Survey 2. Strategic Plan VII.
Agenda of the July 23, 2022 AAD/A Board of Directors meeting.
Honorary Members – Confidential AR 2. Gold Medal Recipient – Confidential IO 20 B.
Promising therapeutic developments for cutaneous lupus erythematosus: Interfering with interferon
By Warren R. Heymann, MD, FAAD Aug. 17, 2022 Vol. 4, No. 33 Disfigurement due to scars and dyspigmentation complicating discoid lupus erythematosus (DLE) can be devastating. The cornerstones of therapy for cutaneous lupus erythematosus (CLE) are steroids (topical, intralesional, systemic) and antimalarials (hydroxychloroquine, chloroquine, quinacrine). Secondary agents include immunosuppressive
Step 2: Learn the MIPS categories
Report with DataDerm ... The Academy’s Qualified Clinical Data Registry DataDerm allows streamlined reporting on MIPS categories, including dermatology-specific measures available nowhere else. ... Learn more about DataDerm . ... Learn more about the MIPS reporting categories before you determine your level of participation. The weights and requirements of the
After 23 years, a syndrome converted me into an eflornithine believer
By Warren R. Heymann, MD, FAAD July 12, 2023 Vol. 5, No. 28 I learned that Vaniqa (eflornithine - ... α -difluoromethylornithine [DFMO]) was discontinued. Topical eflornithine was released in 2000 to reduce facial hirsutism. When the drug was released, I recall being fascinated by the premise of its mechanism.
Impact Report — Vol 5, Issue 2
In a time of shifting health care policy, workforce challenges, and evolving public expectations, your Academy’s commitment to protecting and advancing our specialty has never been more critical. ... From Congress to state legislatures, we’ve led focused efforts to advocate for fair payment policies and protections against inappropriate scope of
Impact Report — Vol 4, Issue 2
Assessing, acting, accomplishing. The Academy does a lot for members by listening to you, assessing your needs, and keeping on the pulse of your interests. We follow through with action. In this ... Impact Report , read about our continued efforts to advocate for you and your practice on Capitol
Impact Report — Vol 3, Issue 2
Seen, heard, valued. The AAD/A ... Impact Report isn’t just a chronicle of Academy wins for our members (although it is ... that, too), it’s an ongoing confirmation that we are listening to you, responding to your needs, and giving you the tools you require to grow in your profession.
Impact Report — Vol 3, Issue 2
Seen, heard, valued. It all adds up. Whether it’s advocating for you on the Hill, supplementing our coding resources, positioning the specialty, or enhancing and adding to your member benefits, it all builds something bigger and stronger for dermatology. ... Read about our most current advocacy efforts, specialty positioning initiatives,
PDF of Boards Fodder for Surgical complications Part 2: Long-term complications of cutaneous surgery
Academy of Dermatology | Association directions in residency boards fodder Surgical complications, part 2:
2020 Legislative Conference Overview of Asks
Suzan DelBene, D-WA, Mike Kelly, R-PA, Ami Bera, MD, D-CA, and Roger Marshall, MD, R-KS.
Agenda for the Nov. 5, 2022 meeting of the AAD and AADA Board of Directors meetings.
July 23, 2022 2. August 23, 2022 B.
The nexus of VEXAS syndrome
By Warren R. Heymann, MD, FAAD December 1, 2021 Vol. 3, No. 47 You may not be familiar with VEXAS (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) syndrome, but it is conceivable that you have already unknowingly encountered patients with the disorder. ... To appreciate the clinical nuances of the VEXAS
Sweating over sweat gland carcinomas: Part 2 — Eccrine mucin-producing sweat gland carcinoma
By Warren R. Heymann, MD, FAAD Aug. 20, 2025 Vol. 7, No. 33 As I write this commentary, March Madness is underway. According to the NCAA, the odds of predicting all 63 NCAA tournament games correctly are approximately 1 in 9.2 quintillion (a quintillion is 10 to the 18th power).
AAD Innovation Academy 2020 Technical Exhibitor Prospectus
IMPORTANT CHANGES 3 New and/or revised rules are identified with this designation. 2 |
Information freeway
Accessibility and technology drive changes to clinical publication model. ... Feature ... By Andrea Niermeier, Contributing Writer, June 1, 2024 These days, discovery in medicine is a freeway of innovation, an autobahn in the science world where the pace is only limited by the speed of minds — and perhaps
An appetite for healthy skin
Can diet affect dermatologic health? Experts weigh in on the evidence. ... Feature ... By Emily Margosian, assistant editor, November 1, 2020 You are what you eat — more than just a mantra, the phrase encapsulates a growing public desire for food-based solutions to targeted health outcomes. However, mixed media
Applying the 2021 E/M coding concepts in everyday practice – Part 2
In our ongoing efforts to help members navigate the E/M changes in a simplified and relatable manner in everyday practice, part two of the AADA’s clinical vignettes focuses on the application of the concepts necessary to support reporting a high level of number and complexity of problems addressed, data analyzed,
Evaluation and management (E/M) coding changes are coming in 2021 – Part 2
Recognizing the 2021 E/M code descriptor revisions ... Changes to E/M coding will go into effect on Jan. 1, 2021. This article follows up on ... part one of our series which introduced the reasoning for these coding changes. We will now focus on key changes for each of the
PDF of proposed guidelines on AD and phototherapy
1 1 DRAFT 2 3 Title: Guidelines of care for the management of atopic dermatitis in adults with
PDF of AD guidelines on phototherapy supplement
J Dermatol. 2015;42(2):129-139. 22.
PDF of gross and micro abstract programs
Parasitology research, 90(2), 87-99. 2.
2023 Annual Meeting Technical Exhibit Prospectus
services in the following categories: 1 • Pharmaceuticals (both prescription and nonprescription) 2
AAD Annual Meeting Past International Registrants
3 El Salvador 3 Croatia 2 Oman 3 ICELAND ALGERIA Malaysia Estonia Bolivia 4 2 3 3 Estonia 2 2 SRI LANKA
PDF of Break-up Best Practices Tool
Questions / Considerations Payer Contracting Termination Survey Questions Scoring Options Your Score 1 2
Previous AAD Annual Meeting registration statistics
3 El Salvador 3 Croatia 2 Oman 3 ICELAND ALGERIA Malaysia Estonia Bolivia 4 2 3 3 Estonia 2 2 SRI LANKA
03-06-17 email ballot
Email Ballot - November 5, 2016 Approve Do not approve Recuse or Abstain Pull for Board Discussion 0 2
20190304 Email Results
Directors Minutes: November 3, 2018 Approve Do Not Approve Abstain/Recuse Pull for Board Discussion 0 2
02-19-18 AADA email results
Directors Minutes: November 4, 2017 Approve Do Not Approve Abstain/Recuse Pull for Board Discussion 0 2
Keeping up is hard to do: The need for true grit
By Warren R. Heymann, MD Oct. 5, 2017 One of the daunting challenges in practicing dermatology (or any branch of medicine) is keeping abreast of advances in the literature to optimize patient care. As a clinician-educator, I have always had an interest in how we learn best. For full disclosure,
Does the JAK inhibitor baricitinib raise the bar on treating lupus?
By Warren R. Heymann, MD Aug. 20, 2018 Cutaneous lupus in dermatomal distribution. Erythematous papules in a dermatomal distribution along the patient's left lower extremity. ... Credit: ... JAAD Undeniably, the JAK inhibitors have been at the forefront of advances in immunologically-based diseases, including alopecia areata, vitiligo, psoriasis, rheumatoid arthritis,
2025 AAD Annual Meeting Global Education Day | International Eczema Council Agenda
IEC Symposium at Global Education Day - AAD 2025 Thursday, March 6, 2025 | 2 – 6 PM ET Orange County
05-20-17 email ballot
Directors Minutes: March 6, 2017 Approve Do Not Approve Abstain/Recuse Pull for Board Discussion 0 2
11-05-16 BOD ballot
Awards: Approve for Information Only Approve Do No Approve Abstain/Recuse Pull for Board Discussion 0 2
Email ballot from the May 21, 2022 AAD/A Board of Directors meeting.
Total Finished Survey: 2 41.
04-28-18 email ballot
Directors Minutes: February 19, 2018 Approve Do Not Approve Abstain/Recuse Pull for Board Discussion 0 2
07-29-17 ballot
Approve Do Not Approve Abstain/Recuse Pull for Board Discussion 0 2 4 6 8 10 12 14 16 18 20 22 24 26
11-04-17 email ballot
Approve Do Not Approve Abstain/Recuse Pull for Board Discussion 0 2 4 6 8 10 12 14 16 18 20 22 24 26
PDF of IPS agenda
Peeling Around the World 2022 March 24; 2:00 – 6:00 p.m.
International Peeling Society agenda
Peeling Around the World 2023 March 16th 2:00 – 6:00 p.m.
Approved email ballot for the March 28, 2022 AAD/A Board of Directors meeting.
Total Finished Survey: 2 4AAD Board of Directors Online Ballot 1.
PDF of psoriasis phototherapy guideline supplemental tables
2 2 Fitzpatrick skin Initial dose, J/cm Increments, J/cm Max Dose, J/cm 1 type I 0.5 0.5 8 II 1.0
Results of the July 23, 2022 AAD/A Board of Directors online ballot.
Total Finished Survey: 2 41.
PDF of CCTF meetings.
As of 2/27/2020 AAD-CSD Leadership Meeting Silver A - HR Friday, 3/20/2020, 1:00 PM-2:00 PM AAD/
Information on COVID-19 testing
For a picture of the CDC test kit see Attachment 2.
PDF of proposed bylaws amendment
Two (2) members of the Nominating Committee shall be elected by the Board of Directors; two (2) shall
The email ballot for the Nov. 6, 2021 AAD and AADA Board of Directors meetings.
the AAD Board of Directors Minutes Approve Do Not Approve Abstain/Recuse Pull for Board Discussion 0 2
AM22 International Eczema Council Agenda
Patients Global Education Day at AAD 2022 | Boston, MA, USA Room 151AB | Thursday, March 24, 2022 | 2:
PDF of CPT billing codes of common procedures
17111 Non-axillae areas 64653 First lesion 17000 OnabotulinumtoxinA Units + qty J0585 Cryosurgery of 2-
PDF of AD topical therapies comment supplemental appendices
AE) 2 c d 1 randomized not serious not serious serious serious none 2/10 (20.0%) 0/9 (0.0%)
A review of the elements of MDM that will apply to E/M coding starting Jan. 1, 2021.
and Analyzed Number and Complexity Risk of Complications and/or Morbidity or Mortality of (Based on 2
PDF of EM quick coder
and Analyzed Number and Complexity Risk of Complications and/or Morbidity or Mortality of (Based on 2
PDF of BF for Darier and Hailey-Hailey diseases
AD complete penetrance, variable expressivity AD complete penetrance, variable expressivity 2+ 2+ ATP2A2
AAD 2021 Summer Meeting Product Sessions policies and guidelines
o Two (2) Signs: one (1) sign placed outside of the Product Session; one (1) placed at the entrance
2026 Annual Meeting President's Gala sponsorship packages
Your support will help the Academy build a stronger, more equitable future in skin health through: 2
2023 Global Education Day - International Eczema Council agenda
IEC Symposium at Global Education Day - AAD 2023 Thursday, March 16, 2023 | 2 – 6 PM CT Ernest
PDF of BF GVHD
HLA incompatibility 60-70% (most important) (most common) 2.
PDF of AAD Atopic Dermatitis diagnostic testing supplement draft
Supplemental Table 2.
2023 Annual Meeting product sessions policies and guidelines
There will be two (2) theaters, and eleven (11) available session times during the Annual Meeting.
International Psoriasis Council agenda
American Academy of Dermatology (AAD) New Orleans, Louisiana, United States Thursday, March 16, 2023 | 2:
PDF of NAHS applicant checklist
Download and review the Orientation Handbook 2.
PDF of MIPS readiness checklist
to prepare your for MIPS reporting. 2019 MIPS Readiness Checklist 1 Determine if you are eligible 2
Modifier madness
Cracking the Code ... Dr. Miller, who is in private practice in Yorba Linda, California, represents the American Academy of Dermatology on the AMA-CPT Advisory Committee. ... By Alexander Miller, MD, April 1, 2019 Test your knowledge: Modifier madness ... Take the quiz to see if you're up to date.
Amount and/or complexity of data to be reviewed and analyzed
What is data and what is "amount and complexity?": In a nutshell ... Data includes review of medical records, tests, and/or information obtained from another source. It also includes ordering tests and analyzing results for the encounter. ... Data is divided into three categories: ... Tests, documents, orders, or information
2024 Documentation tips for MIPS 503
G30.0, G30.1, G30.9, G31.01, G31.09, G31.84, G40.909, I67.850, R41.0 aad.org/measures Page 2
Hands-On Cosmetics Agenda
Mid Face Jennifer Sawaya, MD, FAAD – Moderator Ardalan Minokadeh, MD, PhD, FAAD - Injector 1:00pm-2:
PDF of Contact dermatitis
Hydroxyethyl methacrylate 2012 30 Artificial nails, dental work - (HEMA) 2% pet.
PDF of Contact dermatitis allergens
Hydroxyethyl methacrylate 2012 30 Artificial nails, dental work - (HEMA) 2% pet.
2022 Annual Meeting Product Session policies
There will be two (2) theaters, and eleven (11) available session times during the Annual Meeting.
2022 Annual Meeting Medical Attendee List Rental
other member information, including but not limited to phone or fax numbers and e-mail addresses. 2.
2025 AAD Annual Meeting | Industry Sessions Guidelines
There will be two (2) theaters, and eighteen (18) available session times during the Annual Meeting.
An acne vaccine to make patients happy CAMPers?
By Warren R. Heymann, MD Nov. 12, 2018 When walking back to my office after receiving my flu shot, I thought about how wonderful it be to have a preventive therapy for common dermatologic disorders such as acne. That may not be so far-fetched. ... Acne vulgaris (referred to as
Melanoma: Tracking and Evaluation of Recurrence — Measure 509
Melanoma: Tracking and Evaluation of Recurrence ... DESCRIPTION: Percentage of patients who had an excisional surgery for melanoma or melanoma in situ with initial American Joint Committee on Cancer (AJCC) staging of 0, I, or II, in the past 5 years in which the operating provider examines and/or diagnoses the
PDF of Cutaneous squamous cell carcinoma staging, risk classification, and management
staging Primary tumor (T) Size Features Tx Primary tumor cannot be assessed Tis Carcinoma in situ T1 ≤2
PDF of Lymphomas
Zone B-cell Extremities papules, plaques or bcl-2 XRT Lymphoma nodules Negative: CD5, CD10, Surgical
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention — Measure 226
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention ... DESCRIPTION: The percentage of patients aged 12 years and older who were screened for tobacco use one or more times within the measurement period and who received tobacco cessation intervention during the measurement period or in the six months
2023 AAD Annual Meeting Global Education Day of Dermatology Policies & Guidelines
The request requires a 1 , 2 , and rd 3 choice of session time.
February 6
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / February 6, 2019 ... Nearly half of U.S. physicians are burned out AAD/A CEO announces departure this spring Anthem to institute new modifier 25 payment policy Researchers create new protein that
PDF of proposed legislation from Massachuesetts on modifier 25
Murray 10th Worcester 2/6/2023 James B.
AR - Membership Criteria
The Bylaws define \223Fellows\224 in Article III, Section 2\(a\ \(a\ Fellows.
GP - President's Gala
Current Officers, Directors and Observers of the AAD Board of Directors \(with 1 guest\ 2.
PDF of Inborn errors of metabolism
boards’ fodder #2 Inborn Errors of Metabolism by Kristina Burke, MD, and Erin Adams, MD DISORDER DEFECT
PDF of important dates
Nominating Committee meets to selects final slate 2.
Rounds on pityriasis rotunda
By Warren R. Heymann, MD, FAAD Aug. 7, 2024 Vol. 6, No. 32 Science, medicine, and patient strife aside, sometimes I just admire the beauty of skin lesions in and of themselves. Round, annular, and targetoid lesions (fixed drug eruptions, granuloma annulare, tinea, subacute lupus, erythema multiforme, erythema migrans, and
2024 AAD Annual Meeting Industry Product Session Guidelines
There will be two (2) theaters, and eighteen (18) available session times during the Annual Meeting.
Red alert: Avoid brimonidine and oxymetazoline as hemostatic agents
By Warren R. Heymann, MD June 19, 2017 Mohs micrographic surgery procedure including brimonidine treatment: skin before application (A), 5 minutes after application of brimonidine (B), and minimal intraoperative bleeding with pretreatment of brimonidine (C). ... Credit: ... JAAD As a youth, I recall that "rosy cheeks" were a sign
PDF of AAD Election Call for Nominations Board Values
Everyone comes to the meeting prepared, having reviewed all their meeting materials prior to arrival. 2.
PDF of Board Values for AAD Election Call for Nominations Vice President
Everyone comes to the meeting prepared, having reviewed all their meeting materials prior to arrival. 2.
PDF of 2025 Board Values
Everyone comes to the meeting prepared, having reviewed all their meeting materials prior to arrival. 2.
PDF of 2023 MPFS dermatology codes
Description Non- Payment Payment Payment HCPCS Facility total Facility Amount $ Amount $ Difference 2
PDF of Derm Codes RVUs
Payment Description Non- Payment Payment HCPCS Facility total Difference Facility Amount $ Amount $ 2
2024 AAD Annual Meeting Global Education Day Policies & Guidelines
• Applications received after November 2, 2023 will be accepted based on space availability.
A list of products dermatologists can donate to help combat COVID-19.
Many laboratories that conduct SARS-CoV-2 testing need these supplies, including hospital based and
PDF of industry expert sessions for theater 1.
Hosted by: Leo Pharma 1:30 PM - 2:15 PM Title: Clinical Insights on Ilumya™: IL-23 Inhibitor
Make no bones about it: Primary cutaneous ewing sarcoma is for real
By Warren R. Heymann, MD Aug. 15, 2016 Recently my partner biopsied a verrucous papule from the face of a young boy, without being confident of his clinical impression. Histologically, I knew I was looking at a malignant lesion, but could not identify it. I sent the slide for a
2024 Annual Meeting CCTF meetings
Convention Center Room 9 10518 Advisory Board Reference Committee Hearing 3/8/2024 0:00 3/8/2024 0:00 2:
A novel sebum inhibitor for acne vulgaris: A slick maneuver
By Warren R. Heymann, MD Jan. 11, 2017 Illustrative photos of severe inflammatory acne vulgaris, largely without nodules (A). B, Very severe acne with cysts. ... Credit: ... JAAD What a pleasure it is to think about a novel treatment for acne! Honestly, have you gotten excited learning that the
Low dose isotretinoin for recalcitrant rosacea: I pledge to use it sporadically
By Warren R. Heymann, MD June 14, 2016 While rosacea can usually be reasonably managed with a combination of topical agents (metronidazole, azelaic acid, ivermectin, sulfacetamide, brimonidine), oral antibiotics (the tetracycline family), vascular lasers, intense pulsed light and surgery (for phymatous disease), some cases are recalcitrant to standard therapy. ...
PDF of Neonatal dermatoses
Mouzakis, MD Disease Timing Morphology/Location Work-Up Hints of Onset Erythema Birth - 2 Macules,
PDF of Phototherapy
Theoretically less risk Expensive, spot lesions, especially MED (4-6 times MED) of carcinogenesis size 2
PDF of AAD President-Elect Position Description
Board of Directors – 8/9/14 Revised: Board of Directors – 1/1/17 Revised: Board of Directors – 11/2/
Gains in Patient Activation Measure (PAM) Scores at 12 Months — Measure 503
Gains in Patient Activation Measure (PAM®) Scores at 12 Months ... DESCRIPTION: The Patient Activation Measure (PAM) is a 10- or 13-item questionnaire that assesses an individual’s knowledge, skills, and confidence for managing their health and health care. The measure assesses individuals on a 0-100 scale that converts to one
Exhibitor FAQs for VMX 2021
A: Friday, April 23, 2021 Unopposed time 1:00pm – 2:00pm, Platinum Level Industry Sessions & Exhibits
Glomus tumors point a finger at neurofibromatosis
By Warren R. Heymann, MD ... Nov. 21, 2016 ... The correct diagnosis of the ... JAMA Dermatology Clinicopathological Correlation of a glomus tumor presenting as longitudinal erythronychia was straightforward — I was fascinated by this comment in the discussion: "The presence of multiple glomus tumors in the digits
PDF of 2025-2026 Nomination & Election Timeline
Nominating Committee meets to selects final slate 2.
PS-Electronic Documenting and Administrative Burdens
Electronic Documentation and Administrative Burdens \(Approved by the Board of Directors: November 2,
PDF of Granulomas
female to male Unknown: possibly Classic: annular plaque on Two patterns: Observation lare affected; 2/
2018: Merit-based Incentive Payment System (MIPS)
Eligibility: Physicians, PAs, NPs, Clinical Nurse Specialists, and Certified Nurse Anesthetists who billed ≥ $90,000 in Medicare Part B allowed charges and saw more than 200 Medicare Part B patients ... Reporting year: January 1st, 2018 – December 31st, 2018 ... Data completeness: At least 60% of All Payer Data
A list of published and in-progress analyses based on the COVID-19 Dermatology Registry.
Journal of the American Academy of Dermatology. 2020;83(2):486-492. doi:10.1016/j.jaad.2020.05.109
Key messages in social media about eczema
Key messages ... Eczema refers to a group of conditions that lead to inflamed skin. Signs of inflamed skin include a rash, itchiness, and excessive dryness. (1) ... There are several types of eczema. Atopic dermatitis is the most common type. ... Eczema is a complex condition. Your genes, immune
PDF of becoming a vaccinator site document
Within this information hub, there is a section detailing 2 physician requirements and support information
Predicting malignancies in Sweet syndrome has become sweeter
By Warren R. Heymann, MD Feb. 8, 2018 Histiocytoid Sweet syndrome. A, Multiple round erythematous papules and plaques on trunk and upper limbs. B, Multiple erythematous papules and plaques grouped in figurate pattern on the right thigh of a pediatric patient. C, Erythematous figurate annular plaques with erythematous elevated borders
Naltrexone therapy for Hailey-Hailey disease: Confirming my addiction to evidence-based medicine
By Warren R. Heymann, MD Aug. 28, 2017 Hailey-Hailey disease. Patient 1: erythematous-crusted plaques on the lower midback before radiation treatment. ... Credit: ... JAAD I was fascinated by a presentation at the recent World Congress of Pediatric Dermatology discussing improvement of epidermolysis bullosa wounds with topical CBD (cannabis) oil.
PDF of Academy practice checklist for COVID-19
including fever and/or cough and/or runny nose with or □ Using the WHO recommended products in Box 2,
Say it ain’t so: Dark chocolate exacerbates acne!
By Warren R. Heymann, MD May 5, 2016 Diet and acne has always been controversial. When I was a child I heard that pizza and chocolate could lead to break-outs; over time that was relegated to be a myth (thank goodness). ... The latest foods that have may possibly lead
Promising therapeutic developments for cutaneous lupus erythematosus: Interfering with interferon – Part II – Focus on Anifrolumab
By Warren R. Heymann, MD, FAAD Sept. 13, 2023 Vol. 5, No. 37 This is an exciting time for cutaneous lupus erythematosus (CLE). Recently published findings from three clinical trials show substantial progress in developing more targeted, efficacious, and better-tolerated medications for patients with CLE, particularly by inhibiting the production
AADA bylaws
AADA1 Section 2.
PDF of Boards Fodder Local anesthesia
epinephrine 7 490 60-400 onset cy (Category B) Michael Plain 5.0 350 30-120 Articaine Septocaine® 2-
PDF of AADA President-Elect Position Description
Board of Directors – 8/9/14 Revised: Board of Directors – 1/1/17 Revised: Board of Directors – 11/2/
Mucho de Mucha-Habermann
By Warren R. Heymann, MD Dec. 19, 2016 As we approach interview season for our residency program, I try to think of some questions I haven’t asked before. I usually do not discuss dermatologic disorders per se, as I am more concerned about the interviewee as a person knowing how
Desquamative gingivitis: Sinking your teeth in miagnosis and management
By Warren R. Heymann, MD Jan. 7, 2017 Cycle of oral hygiene in desquamative gingivitis. ... Credit: ... JAAD Patients presenting with desquamative gingivitis (DG) are typically some of the most frustrated, aggravated patients I encounter. Frequently, they have not been adequately evaluated, are in pain, and are desperate for
Can oral ivermectin cure pediatric periorificial dermatitis? It mite!
By Warren R. Heymann, MD March 5, 2017 A 13-year-old boy with severe rosacea before (A) and 1 month (B) and 4 months (C) after receiving oral therapy with a single dose of 250 μg/kg ivermectin (case 3). Note the facial desquamation after the first weeks of therapy, not attributable
PDF of measure AAD8 documentation template
Dermatitis • Alopecia • Acne • Vitiligo • Rosacea • Keloids • Urticaria • None of the Above 2.
AR - Procedures for Proposed Amendments to the Articles of Incorporation and Bylaws
5/15/2021 Approved: Board of Directors \226 6/21/84 Revised: Board of Directors \226 6/24/90; 8/2/
Practice Safe Sun Instagram giveaway rules
How to enter the #PracticeSafeSun Giveaway (the “Contest”): 1) Follow @aadskin1 on Instagram. 2)
You like tomato, I like tomahto, you soak with steroids, I use them dry…
By Warren R. Heymann, MD July 28, 2016 I have been a firm believer in the “Soak and Smear” approach to treating recalcitrant dermatoses, including atopic dermatitis, as detailed by Gutman et al, more than a decade ago. The authors defined soaking and smearing as soaking an affected body part
A sweeter approach to treating scleroderma?
By Warren R. Heymann, MD March 14, 2017 Scleroderma fingernail changes. A, Longitudinal ridging and pitting. B, Brachyonychia. C, Trachyonychia. D, Thickened and enlarged cuticles. E, Thickened, enlarged, and irregular cuticles. F, Nailfold capillaroscopy: presence of enlarged and giant capillaries. G, Nailfold capillaroscopy: presence of enlarged and giant capillaries,
A ioint ACR, AAD, RDS, and AAO statement on hydroxychloroquine use with respect to retinal toxicity
Medicine, Ophthalmology, and Cell Biology Oregon Health & Science University Portland, Oregon 97239 2
PDF of psoriasis phototheraphy guideline treatment pathway
continue as therapy or continue as combination combination combination excimer laser for See table 2
2026 AAD Annual Meeting: Global Education Day
Global Educational Day of Dermatology at the 2026 AAD Annual Meeting is an opportunity for international societies who are ... member organizations of the ... International League of Dermatological Societies (ILDS) to hold an independent educational session the day before the official start of the AAD Annual Meeting on Thursday,
PDF of syndromic surveillance specs
PI_PHCDRR_2_PRE Engagement 2.
2026 AAD Annual Meeting | Global Education Day Policies & Guidelines
ELIGIBILITY: Approved ILDS members by the AAD are eligible to hold a two (2) or four (4) hour session
Eruptive pseudoangiomatosis is real
By Warren R. Heymann, MD, FAAD May 4, 2022 Vol. 4, No. 18 The term "pseudo" (defined as false, fake, or unreal) is used liberally in dermatology, much to the chagrin of students of the discipline and non-dermatologists. There are dozens of examples (pseudofolliculitis barbae, pseudo-Kaposi sarcoma, pseudolymphoma, etc. —
Breaking through
Go to AAD Home ... Go to AAD Home ... Menu ... Advances in disease pathogenesis and treatments offer new promise for patients with connective tissue disease ... Advances in disease pathogenesis and treatments offer new promise for patients with connective tissue disease ... By Allison Evans, assistant managing editor
PDF of Measure 224.
diagnosis of Stage 0 through IIC melanoma without signs or symptoms suggesting systemic spread OR 2)
PDF of urticaria guidelines for comment
J Allergy Clin Immunol. 1999;103(2 Pt 1):307-314. 23.
AM22 Global Education Day of Dermatology Policies & Guidelines
ELIGIBILITY: Confirmed ILDS members are eligible to hold a two (2) or four (4) hour session.
PDF of global education day policies
ELIGIBILITY Confirmed ILDS members are eligible to hold a two (2) or four (4) hour session.
PDF of mailing policies
ELIGIBILITY Confirmed ILDS members are eligible to hold a two (2) or four (4) hour session.
PDF of Global Education Day policies
ELIGIBILITY Confirmed ILDS members are eligible to hold a two (2) or four (4) hour session.
The aryl hydrocarbon receptor: Tapinarof is taking off
By Warren R. Heymann, MD, FAAD Nov. 19, 2025 Vol. 7, No. 46 In his outstanding lecture identifying drivers of lupus, presented at the 2025 meeting of the Medical Dermatology Society, Jaehyuk Choi MD, PhD, explained that interferon — the well-known nemesis of lupus — controls the production of T
The alphabetization of lymphomatoid papulosis: Focus on “F”
By Warren R. Heymann, MD April 3, 2017 Follicular lymphomatoid papulosis. Recurrent papulonodular lesions on face (A to C). Patient had similar lesions on extremities. ... Credit: ... JAAD Seven years ago, today (April 3rd, 2010) my wife purchased an iPad on its inaugural release date. The only choices to
2025 AADA Legislative Conference: Program and agenda
Conference schedule ... The conference will take place on Sunday, September 7 through Tuesday, September 9, 2025, at the J.W. Marriott in Washington, D.C. The program will contain policy-focused sessions, designed to offer an in-depth understanding of how to translate the issues that affect the specialty into effective lobbying of
Increasing evidence for the use of topical timolol for pyogenic granulomas
By Warren R. Heymann, MD May 16, 2016 There are multiple approaches to treating pyogenic granulomas (PGs). If possible, I usually perform a shave biopsy and electrodesiccate the base of the lesion. Certainly there are times when that approach may not be optimal, such as a PG the face of
PDF of Spanish Academy of Dermatology and Venereology Global Education Day presentation
Share the main contributions of AEDV in cutaneous manifestations of COVID- 19 from the last 2 years.
The medical word to watch in 2018: Dysbiosis
By Warren R. Heymann, MD Jan. 4, 2018 With increasing rapidity, new words enter the dermatological lexicon, reflecting concepts that change our perceptions of disease and treatment. Recent examples include "comorbidities," "programmed cell death inhibition," and "teledermatology". The word to watch in 2018 is "dysbiosis." ... The microbiome has been
The appeal of molecular medicine for the peeling skin syndrome
By Warren R. Heymann, MD April 17, 2018 A, After soaking his foot in warm water for 30 minutes, the patient could peel superficial layers of skin. B, After the peeling, erythematous base is revealed. C, Healed area with slight thickening and pigmentation. ... Credit: ... JAAD This may not
Old stains leaving new marks in dermatology
... By Warren R. Heymann, MD Oct. 15, 2018 A new blue-gray papule was noted on the left side of the neck and was excised as outlined by gentian violet surgical marker. ... Credit: ... JAAD Periodically I will pull an ancient tie from my rack. I’m delighted if
August 27, 2025
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Aug. 27, 2025 ... A tool to assess patients at high-risk for cutaneous squamous cell carcinoma DermWorld Insights and Inquiries : Chanarin-Dorfman syndrome — Shifting out of neutral Carbon dioxide laser
PDF of Dermatologic manifestations of underlying endocrinology
Widened teeth spaces + Addison’s Disease Auricular calcification; Hair may Fatigue u ACTH, u K + +2
Diminishing diagnostic cognitive bias: Anchors away
By Warren R. Heymann, MD, FAAD Sept. 27, 2023 Vol. 5, No. 39 We have all been there, probably daily. You’re an hour behind schedule, and the patient in front of you has a laundry list of complaints demanding that you address them. You shift to autopilot, using your keen
Position description for AAD Public Social Media Correspondent
CORRESPONDENT POSITION DESCRIPTION Title: AAD Public Social Media Correspondent Term: 2